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Summary 
This thesis contributes to the understanding of the psychosocial factors 
associated with skin conditions and the lived experience of visible 
difference. Chapter one is a systematic literature review that identifies the 
psychosocial factors associated with the onset and living with alopecia for 
children and young people. A systematic review of the literature indicated 
relational factors and frequency of negative life events were associated 
with the onset of alopecia for young people. Although the findings into the 
psychosocial factors associated with living with alopecia are mixed, anxiety 
was the most frequently reported factor for children and young people.  
The quality of the papers included in the review are mixed, with varying 
population samples, measures and methodological limitations. Clinical and 
research implications are discussed.          
                      
Chapter two is a qualitative research study that explored the lived 
experience of six women with rosacea using interpretative 
phenomenological analysis (IPA). Participants’ experiences of rosacea were 
characterised by an internal struggle to feel in control of their skin 
condition whilst externally, learning to navigate complex social 
interactions.  Clinical and research implications are discussed.  
 
Chapter three is a reflective account of the researcher’s experiences during 
the research process. The researcher’s reflections have been structured 
around the Acceptance and Commitment Therapy (ACT) Hexaflex model. 
Particular attention has been paid to the experiences that reflect the 
researcher’s values, cognitive defusion, acceptance, contact with the 
present moment, self as context and committed action.  
 
Overall Word Count:  18,592
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1.0 Abstract:  
Aim: The pathogenesis of alopecia is complex and the inclusion of various 
age ranges in previous systematic reviews has made it difficult to 
understand the psychosocial factors related to young people with the 
condition. This review aims to identify the psychosocial factors associated 
with onset and living with alopecia for children and young people.  
Method: A systematic review of the literature was completed across eleven 
databases, together with the use of reference and citation searches. A web 
search engine was also searched to identify relevant grey literature. A total 
of nineteen studies were identified.  
Results:  Relational factors and number of negative life events were 
associated with the onset of alopecia. Anxiety was the most frequently 
reported factor for young people living with the condition. Other factors 
discussed included quality of life, self-esteem, systemic difficulties and 
coping strategies.                       
Conclusion: The quality of the papers are mixed with varying population 
samples, measures and methodological limitations. The review highlights 
the importance of a holistic assessment of needs and the use of services to 
support young people and their families. Other research and clinical 
implications are discussed.  
Key words: Alopecia, young people, psychosocial factors, review 
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1.1 Introduction:  
1.1.1 Alopecia 
It is widely acknowledged that hair follicles have important physiological 
functions particularly within temperature regulation, obtaining sensory and 
tactile information and protection from UV light (Blume-Peytavi, Kanti & 
Vogt, 2016). For humans, hair has also become a symbol of great 
psychological and social importance, playing a key role in the development 
of self-identity, social interaction, sexual attraction and communication 
(Blume-Peytavi et al., 2016; Farrant & McHale, 2014). Within the literature, 
research into conditions that cause visible hair loss, particularly on the 
scalp suggests it can have a devastating impact on psychological and social 
wellbeing (Hunt & McHale, 2005b). 
 
 Alopecia is a term often used to define a broad range of hair loss 
conditions which are typically grouped into two main categories: non-
scarring and cicatricial (scarring) alopecia (American Skin Association, 
2012). Although the estimated prevalence rates and symptom trajectory 
varies between the two categories, broadly speaking both are marked by 
the thinning or loss of hair that has arisen from a disruption to the hair 
growth cycle (Bouhanna, 2016). For both categories of alopecia, the 
pathogenesis of the condition is complex, with various inflammatory, 
autoimmune, genetic, hormonal and psychosocial factors implicated in the 
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aetiology of the condition (Dinh & Sinclair, 2007; Madani & Shapiro, 2000; 
McElwee et al, 2013).  
 
Non-scarring forms of alopecia are the most prevalent forms of hair loss 
and are defined by a reduced hair density on the scalp (androgenetic 
alopecia), loss of hair in patches (alopecia areata), across the whole scalp 
(alopecia totalis) and across the scalp and body (alopecia universalis) 
(Delamere, Sladden, Dobbins & Leonardi-Bee, 2008). As the hair follicle can 
re-grow, the majority of people living with the condition will experience 
reoccurring episodes of hair loss across their lifespan (Messenger, 
McKillop, Farrant, McDonagh & Sladden, 2012; Papadopoulos, Schwartz & 
Janniger, 2000). Whilst the two categories of alopecia are largely distinct, 
over time, it is possible for non-scarring alopecia to develop a biphasic 
pattern similar to the trajectory of hair loss associated with cicatricial 
alopecia (Somani & Bergfeld, 2008).  
 
Although the understanding of cicatricial alopecia is limited, in these cases 
the processes that are thought to cause the hair loss also destroy the hair 
follicle and lead to the surrounding skin to become scarred (Price & 
Mirmirani, 2011).  Unlike non-scarring alopecia, this prevents any 
opportunity for hair re-growth, leading to the permanent loss of hair on 
the scalp (Chiang & Al-Niaimi, 2012). Whilst both cicatricial and non-
scarring alopecia have a minimal effect on general physical health, they 
5 
 
pose a significant challenge to clinicians as they are difficult to treat, often 
chronic in nature and are associated with a number of social and 
psychological factors (Messenger et al., 2012; Pradhan, D'Souza, Bade, 
Thappa & Chandrashekar, 2011). 
 
1.1.2 Pathogenesis of alopecia 
Research into the onset of alopecia has predominantly focused on 
understanding the different biological and medical factors that underpin 
the hair loss (Delamere et al., 2008). Preliminary research into the mind-
body link indicates that the presence of psychosocial factors can mediate 
the biological mechanisms responsible for inhibiting hair growth (Arck, 
Slominski, Theoharides, Peters & Paus, 2006; Garcia-Hernandez, Ruiz-
Doblado, Rodriguez-Pichardo & Camacho, 1999). More specifically, it is the 
presence of stressful life events (Brajac, Tkalcic, Dragojevi & Gruber, 2003), 
affective disorders (Gupta, Gupta & Watteel, 1997), lack of attachment 
security (Schmidt, 2003) and personality characteristics (Willemsen, 
Haentjens, Roseeuw & Vanderlinden, 2009) which have been associated 
with triggering the onset of alopecia and/or the aggravation of pre-existing 
symptoms. Whilst this suggests an association between the onset of 
alopecia and the presence of a psychosocial factor, the pathogenesis of 
alopecia is complex, with studies reporting conflicting results across a 
broad range of population samples and age range of participants (Picardi et 
al., 2003; Van Der Steen, Boezemann, Duller & Happle, 1992). Despite the 
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methodological limitations of the literature, the conflicting research 
findings indicate further investigation is required in order to broaden the 
understanding of the association between psychosocial factors and the 
onset of alopecia that occurs across the life span.    
  
1.1.3 Psychosocial Factors and Alopecia 
The psychosocial factors associated with living with non-scarring alopecia 
in adults is well documented with anxiety, depression, obsessive 
compulsive disorder , poor self-esteem and poor quality of life frequently 
documented (Alfani et al., 2012; Al-Mutairi & Eldin, 2011; Chu et al., 2011; 
Hunt & McHale, 2005a,; Masmoudi et al., 2013; Sellami et al., 2014). 
Although research into cicatricial alopecia is still in its infancy, poor health-
related quality of life, emotional distress, anxiety and depression have also 
been associated with living with this condition (Chiang, Bundy, Griffiths, 
Paus & Harries, 2015; Katoulis et al., 2015; Pradhan et al., 2011). 
 
Due to the volume of research on alopecia areata, a number of systematic 
reviews have been completed. These reviews consistently make reference 
to the presence of depression, anxiety and poor health related quality of 
life (Fricke & Miteva, 2015; Ghanizadeh & Ayoobzadehshirazi, 2014; Hunt & 
McHale, 2005a; Liu, King & Craiglow, 2016; Tucker, 2009). Whilst these 
reviews help to synthesise the literature, they do not incorporate a quality 
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assessment framework, with some reviews providing limited information 
on the studies they investigated. This can make it difficult to compare and 
critique the quality and findings of the studies and improve future 
psychological research in the topic area (Moher, Liberati, Tetzlaff & Altman, 
2009; NICE, 2012). Furthermore, the majority of the research in this area 
has focused on the adult population and as such the reviews are limited in 
their ability to portray the psychosocial factors associated with living with 
alopecia in young people.  
 
1.1.4 Alopecia and Young People  
Alopecia can develop at any age and although the prevalence rates vary 
within the literature, some types of non-scarring alopecia are more likely to 
develop before adulthood (NICE, 2014b). The age at which the condition 
develops is considered to be an important risk factor in the trajectory of 
the condition, as children with alopecia are more likely to have extensive 
hair loss across the lifespan compared to adults who develop the condition 
(Fricke & Miteva, 2015).  
 
Childhood and adolescence is usually defined as a time of physical change, 
sexual maturation and social development (Cote & Levine, 2016). Typically, 
this stage of life is characterised by the increasing focus on the exploration 
of values and beliefs, seeking more autonomy and focusing on peer 
relationships (Erikson, 1968; Sharma & Lucchetta, 2007). Integral to child 
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development is the importance that is placed on physical appearance, 
particularly within the formation of identity, body satisfaction and youth 
culture (Coleman & Hendry, 1999; Harter, 1999; Holmbeck, 2002). As such, 
visible differences which alter physical appearance can present as an 
additional challenge for a young person to navigate, as it can disrupt the 
trajectory of typical social development (Empson, Nabuzoka & Hamilton, 
2004).  
 
Within the literature, there seems to be an assumption that the 
psychosocial factors associated with alopecia in adults mirror those of 
children and young people (Smith, 2001). However, in light of the 
importance of appearance within normal social developmental processes, 
it is perhaps unsurprising that young people with alopecia areata may have 
higher rates of self-reported depression and anxiety levels compared to 
adults living with the condition (Ghanizadeh & Ayoobzadehshirazi, 2014). 
This indicates further research is needed to explore the psychosocial 
factors associated with alopecia for different age categories, in particular, 
factors specifically related to children and young people.   
 
1.1.5 Rationale and Aims 
Several literature reviews on the psychosocial factors associated with 
alopecia have been conducted (Cash, 2001; Ghanizadeh & 
9 
 
Ayoobzadehshirazi, 2014; Hunt & McHale, 2005a; Tucker, 2009). However, 
the inclusion criteria of these reviews have led to participant samples of 
widely varying age ranges ; making it difficult to understand the 
psychosocial factors specific to children and young people with alopecia. In 
addition, the systematic reviews completed in this area do not consistently 
include a quality assessment framework which presents a challenge in 
establishing the quality and findings of the current literature (Moher et al., 
2009; NICE, 2012). To the author’s knowledge there has yet to be a 
systematic literature review which has investigated the psychosocial 
factors associated with the onset and living with alopecia for children and 
young people. The current review will therefore explore and critically 
evaluate the current literature base to address the following aims:  
 What are the psychosocial factors associated with the onset of 
alopecia in children and young people? 
 
 What are the psychosocial factors associated with living with 
alopecia for children and young people?  
 
1.2 Method 
1.2.1 Ethical Considerations 
The systematic literature review protocol was developed and 
conducted in concordance to British Psychological Society (2009) and 
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Health and Care Professionals Council (HCPC) Guidelines (2016) for 
Ethical Human Research and Conduct.  The research protocol was also 
submitted and approved by the Coventry University Ethics Committee 
(see Appendix B).  
 
      1.2.2 Searches 
1.2.2.1 Database search 
A scoping search of the literature was completed in August 2016. 
Discussions with a Consultant Dermatologist and Clinical Psychologist 
working in the NHS and librarians from the University established 
relevant search terms, databases and differences in spelling of the key 
terms across different countries. The primary and meta electronic 
databases that were searched were Academic Search Complete, Allied 
and Complementary Medicine Databases (AMED), Applied Social 
Sciences Index and Abstracts (ASSIA), Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), EMBASE, Medline, Psych Articles, 
PSYCH info, PROQUEST, Scopus and Web of Science. Google Scholar 
and Open DOAR were also included in the review for the purpose of 
searching for grey literature.  
 
The key search terms used in the database search are included in Table 
1.1.  In order to improve the accuracy of the database searches, free 
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text, subject heading terms and Boolean operators were used (Dundar 
& Fleeman, 2014). Whilst a search string was used as consistently as 
possible, at times the search string and use of Boolean operators had to 
be modified in order to comply with the design of some of the 
databases.  
Table 1.1 Database search strategy 
Concepts Variation/Synonym 
Alopecia Alopecia* OR Childhood alopecia OR "androgenetic 
alopecia" OR "hair shaft abnormalities" OR "tinea 
capitis" OR "traction alopecia" OR "androgenic 
alopecia" OR "female pattern hair loss" OR "female 
pattern baldness" OR "hair loss" OR "hair thinning" 
OR baldness OR "telogen effluvium" OR "cicatricial 
alopecia" OR "non scarring alopecia" OR “non-
scarring alopecia” OR "scarring alopecia" 
Age Child* OR “young person” OR “young people” OR 
adolescent OR teenager OR youth 
Psychosocial 
factors 
"psychosomatic" OR "psychological cause" OR 
"psychosocial factors" OR "psychological factors" 
OR "self esteem" OR psycho* OR psychosocial* OR 
"quality of life" OR mental* OR anxiety OR 
depression OR "psychological distress" OR 
12 
 
"emotional response" OR "lived experience" OR 
mood OR social avoidance OR social interaction 
Excluded 
from the 
review 
drug* OR oral* OR chemo* OR cancer OR 
“leukemia” OR “leukaemia” 
 
In line with previous systematic reviews on alopecia, the term, 
‘psychosocial factors’ was operationalised in the current review as “any 
negative outcomes that affect patients either emotionally, 
psychologically, or socially” (Tucker, 2009, p.143). Although there are 
no specific guidelines on the recommended use of search filters, the 
parameters used in the current review were considered in context of 
balancing the sensitivity and precision of the search strategy (Brettle, 
Long, Grant & Greenhalgh, 1998: Jenkins, 2004). This included limiting 
the key terms to article abstracts that were peer reviewed and 
available in the English Language. Furthermore, a date limit was not 
included in the search parameters in order to identify as much 
information as possible in the context of the broad aims of the review.  
 
Using the key search terms, a systematic search of the literature was 
completed between January and February, 2017. The titles and 
abstracts of papers identified within the stated databases were 
screened against the criteria and those that did not meet the inclusion 
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criteria were discarded (see Table 1.2). Following this, the paper’s full 
text was evaluated against the criteria through which they were either 
excluded or included in the review (see Figure 1.1). Consistent with the 
research proposal, three papers were discussed with the supervisory 
team as to whether they met the criteria.  
 
1.2.2.2 Manual Search 
The reference lists of the articles that met the inclusion criteria were 
examined in order to identify other papers that were not captured in 
the search.  In line with good practice guidelines, a cited search on the 
full text articles that met the inclusion criteria was also completed 
(NICE, 2014a). Titles and abstracts of the articles sourced from 
reference lists and cited searches were initially screened against the 
inclusion/exclusion criteria, followed by a full text review to ensure the 
articles met the criteria of the review. As it is essential for systematic 
reviews to be “thorough, transparent and reproducible” (NICE, 2012),  
Figure 1.1 highlights the search strategy that was completed based on 
the Preferred Reporting Items for Systematic Reviews and Meta 
Analyses (PRISMA) diagram (Moher et al., 2009).   
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Figure 1.1 Search Strategy Flow Diagram 
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1.2.3 Selection Criteria 
1.2.3.1 Inclusion Criteria  
The inclusion/exclusion criteria for the review is included in Table 1.2. As 
alopecia can affect individuals of all ethnicities, cultures and gender 
(Messenger et al., 2012), the criteria for the participant samples were kept 
broad. In order to be consistent with the operational definition of a ‘young 
person’ recommended by the World Health Organisation (1986), the 
current review included papers involving participants up to the age of 25. 
Both quantitative and qualitative methodologies were included as the 
synthesis of articles from a range of methodological approaches can enrich 
the current understanding of physical health conditions (Mays, Pope & 
Popay, 2005).  
 
The inclusion of grey literature was considered as a criteria in order to 
reduce possible article selection bias and to help identify additional articles 
that have yet to be published (Hopewell, McDonald, Clarke & Egger, 2007; 
McAuley, Tugwell & Moher, 2000). For the purpose of the review, grey 
literature was defined as “that which is produced on all levels of 
governmental, academics, business and industry in print and electronic 
formats, but which is not controlled by commercial publishers” (Hopewell 
et al., 2007, p.2).  Any grey literature included in the review will be 
discussed as part of the quality assessment as without this, its inclusion can 
lead to additional bias (Dundar & Fleeman, 2014).    
16 
 
Table 1.2 Inclusion /exclusion criteria  
Inclusion Criteria Exclusion Criteria 
 Studies that explore the 
psychosocial factors 
associated with the onset 
and/or living with alopecia 
 Participants aged up to 25 
years old and/or their 
parents  
 Studies that include 
common types of non-
scarring and scarring 
alopecia 
 Original research that is 
peer reviewed and/or 
contained within grey 
literature  
 Full text available in English 
language  
 Studies where young 
people’s data cannot to be 
separated from adult data 
or other medical conditions  
 Studies that that use 
alopecia as a control group 
to explore other medical 
conditions 
 Articles, reviews and 
opinion pieces 
 
 
 
1.2.3.2 Exclusion Criteria  
Studies in the search were limited to the inclusion of full text availability in 
the English Language.  Whilst this may exclude additional information 
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which could help with the precision and applicability of the findings, in 
many cases the effect of this exclusion criterion has had a minimal practical 
difference on the overall research findings (Juni, Holenstein, Sterne, 
Bartlett & Egger, 2002). Studies that combined the results of participants 
with alopecia and causes of hair loss from other physical health conditions, 
medical treatment and mental health difficulties were excluded from the 
current review. This was to ensure the presence of contextual factors that 
are commonly associated with psychological and social wellbeing in other 
causes of hair loss were excluded in the current review (Flessner et al., 
2008; Williams, Wood & Cunningham-Warburton, 1999).   
 
1.2.4 Quality Assessment  
The inclusion of quality assessments is considered to be an essential 
component of systematic reviews as they help to evaluate the 
methodological quality of the current literature and minimise bias within a 
project (Sanderson, Tatt & Higgins, 2007). As there is currently no 
recommended ‘gold standard’ critical appraisal tool, careful consideration 
is required to ensure the most appropriate quality appraisal tool is chosen 
in relation to the reviewed studies (Katrak, Bialocerkowski, Massy-
Westrop, Kumar & Grimmer, 2004; Sanderson et al., 2007). In light of this, 
papers included in the current review were subject to the quality 
assessment tool devised by Caldwell, Henshaw and Taylor (2005, 2011). 
(See Appendix C). This tool was chosen as it incorporates both generic and 
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specific concepts designed to be relevant to the qualitative, quantitative 
and mixed method approaches and range of research designs used within 
health research (Caldwell, Henshaw & Taylor, 2011).  
 
As the framework does not provide a quality rating score, a scoring system 
was devised comprising: two points were awarded to a paper where 
quality criteria were fully met; one point for partially met quality criteria; 0 
points for quality criteria not being met (See Appendix D for all quality 
assessment scores). Each study was therefore given an overall total score 
which was converted into a percentage quality score. Due to the limited 
volume of research, studies were included in the review regardless of their 
quality assessment score. This can support the generation of new insights 
into a topic area (Noyes et al., 2013). Whilst the literature does not provide 
a universal threshold score to classify ‘high’ and ‘low’ quality papers,  
(Whiting, Harbord & Kleijnen, 2005) for the purpose of the current review a 
paper with a quality rating score of below 50% was deemed to be poor 
quality. The quality rating score for each study is included in Table 1.3. 
 
1.2.5 Quality Assessment Analysis 
Inter-rater reliability testing for the quality assessment framework was 
completed on a random selection of five papers included in the review. A 
summary of the Cohen’s Kappa reliability coefficient for these papers is 
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included in Table 1.3 (See Appendix E for Kappa coefficient data). The co-
efficient scores varied from 0.79-0.91 with an overall Kappa reliability co-
efficacy score of k=0.86. This indicates strong inter-rater reliability (Altman, 
1999). Discrepant findings were discussed. Where divergence occurred it 
seemed to result from a lack of familiarity with the existing literature on 
the part of the rater.  
 
1.3 Review of the literature  
Nineteen papers were identified in the search and a summary of the 
papers is provided in Table 1.3.   All papers recruited participants with non- 
scarring alopecia (alopecia areata, alopecia totalis and alopecia universalis). 
Three papers explored factors associated with the onset of alopecia, twelve 
papers focused on factors associated with living with the condition and 
four papers investigated both aspects. The majority of the studies (n=16) 
used quantitative, rather than qualitative (n=2) methodologies. One study 
used mixed methods.  
 
Studies included in the review involved participants between the ages of 1-
21 years. Research was completed across eleven different countries, with 
most papers being conducted in America (n=6). Information on 
participants’ ethnicity and cultural backgrounds was inconsistently 
reported.  
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The findings have been structured to address the aims of the current 
review, exploring the psychosocial factors associated with the onset of 
alopecia, followed by the factors associated with living with alopecia. As 
none of the papers recruited participants with scarring alopecia, for ease of 
reading in the results and discussion section of the current review the term 
alopecia has been used to refer to participants with alopecia areata, 
alopecia totalis and alopecia universalis.  
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Author, Date, 
Location 
Aim Methodology and Method of data 
collection 
Participant Information and Sampling 
Method 
Main Findings 
 
Quality 
Assessment 
Score 
Al-Okali,  
El-Sourbagy & 
Wassif, 2008 
 
Location: 
Libya 
 
To compare 
depression and 
anxiety in children 
with skin diseases 
 
 
Methodology: Quantitative  
Design: Case Control Design 
Measures: 1) D Test, 2) Anxiety 
Manifest Scale, 3) MMPI Psychiatric 
evaluation, 4) Medical history/ 
clinical examination 
Sampling method: Not reported 
Recruitment: Outpatient dermatology  
Participants: aged 6-14 years  
n = 50 ‘healthy’ control group 
n= 50 participants with skin conditions 
including n=10 with AA (6 males, 4 
females) 
1) No significant difference  (p=>0.05)* in the 
mean depression score between AA ( M=9.6, SD= 
5.2) and control group (M=9.7, SD= 3.3)   
 
2) AA group significantly higher mean (M= 20.2, 
SD= 6.6), anxiety score (M=13.2, SD=5.6) 
compared to control group (p= <0.01)* 
42% 
Andreoli et al, 
2002. 
 
Location: 
Rome 
To explore the 
onset of AA and 
stressful events 
Methodology: Quantitative  
Design:  not reported 
Measures: 1) Clinical interview, 2) 
Paykel’s scale of stressful events, 3) 
HTP, 4) Rorschach diagnostic test 
Sampling Method: Not reported. 
Recruitment: Inpatient dermatology   
Participants: N= 180 with AA, AT, AU. 
54% male, 46% female. Age range 5-16 
years, mean age =9.7 years.  
1) 81% of participants reported stressful event 
prior to AA (e.g. relational problems, pressure of 
expected performance, sibling rivalry). 
2) 45% reported one stressful situation/event 
44% 
Beattie & 
Lewis-Jones, 
2006 
 
Location: UK 
 
To compare HRQOL 
scores in children 
with skin conditions  
 
 
Methodology: Quantitative  
Design: Not reported   
Measures: 1) CLQI, 2) CDLQI  
Sampling: Not reported  
Recruitment: Outpatient dermatology  
Participants: N= 379 aged 5-16 years 
with chronic skin condition and 
diseases.  AA group n=11 (7 male, 4 
female)  
 
 
1) Parents scored AA to have the 5th highest 
impact on child QOL compared to 11 skin 
conditions  
2) Parents QOL score for child higher (18.7%) 
than AA participants score (10%)  
2) Teasing/ bullying the most frequently 
reported in AA compared to 11 other skin 
conditions.   
58% 
Abbreviations: 
Quality of life measures: QOL = Quality of Life, HRQOL= Health related quality of life, CLDQI= Children’s Dermatology Life Quality Index, CLQI= Children’s Life Quality 
Index, LECL = Life Events Checklist, LES=Life Events Scale, FES= Family Environment Scale, PedsQL= Paediatric Quality of Life Inventory 
Mental Health: CAMHS= Child and Adolescent Mental Health Service, RCAMS= Revised Children’s Manifest Anxiety Scale, RCADS= Revised Child and Anxiety and 
Depression Scale, STAI= State Trait Anxiety Inventory, CDS= Children’s Depression Scale, CDRS= Children’s Depression Rating Scale-Revised, CDI= Child’s Depression 
Inventory, CBCL= Child Behaviour Checklist, CMAS = Child Manifest Anxiety Scale, HTP= Graphic House Tree Person Test, SCL-90-R= Symptom Checklist-90 Revised  
Medical terminology: AA= Alopecia Areata, AT= Alopecia Totalis, AU= Alopecia Universalis, AD= Atopic Dermatitis, SALT= Severity of Alopecia Tool 
* = Author observed the paper did not provide full statistical analysis data and/or participant information 
 
 
 
Table 1.3 Data log of the 19 papers in the review 
Table 1.3 Data log of the 19 papers in the review 
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Author, Date, 
Location 
Aim Methodology and Method of data 
collection 
Participant Information and Sampling 
Method 
Main Findings 
 
Quality 
Assessment 
Score 
Bilgic, et al, 
2014 
 
Location: 
Turkey 
 
To assess 
depression, 
anxiety and QOL 
of young people 
with AA.  
 
 
Methodology: Quantitative 
Design: Not reported  
Measures: 1) CDI, 2) STAI, 3) PedsQL, 
4) Demographic form, 5) SALT 
 
 
Sampling method: Not reported 
Recruitment: Outpatient dermatology   
Participants: Age range 8-18 years.  
n=40 AA Child group  
n=34 AA Adolescent group  
n=33 Child control group 
n=32 Adolescent control group 
 
1) State (t=3.16, p<.001) and Trait (t=2.95, p 
<.001, two-tailed)* anxiety scores significantly 
higher in child AA group than control group.  
2) Parents scored children with AA to have 
significantly lower HRQOL scores than control 
group (U= -2.63,  p<.001, two -tailed)* 
3) State anxiety significantly higher in adolescent 
AA group than control group (t=4.04, p<.001, 
two-tailed)* 
4) No significant difference between parent’s 
HRQOL scores of adolescents with AA and 
control group (t=-2.34, p<.02, two-tailed)* (P 
value set at <.01) 
 
64% 
 
(k=0.91) 
Coulacoglou,  
Tchinou, & 
Michopoulou, 
2001 
Location: 
Greece 
To evaluate 
personality 
structure of 
children with 
psychosomatic 
symptoms.  
Methodology: Quantitative 
Case Study: Case Report 
Measures: 1) Fairy Tale Test (FTT), 2) 
Somatic Inkblot Series (SIS), 3)  
Family Drawing Test 
Sample: Not reported 
Recruitment:  Not reported 
Participant: n=1 10 year old male with 
AA, n=1 11 year old female with 
headaches and vomiting  
1) Low self-esteem (T=14.6)* stress and 
depression (T=78)* in child with AA.  
2) Psychosomatic symptoms reflected in the 
avoidance of body imagery.  
17% 
De Waard-
Van Der Spek,  
Raeymaecker,  
Koot, & 
Oranje, 1994 
 
Location: 
Netherlands 
To establish 
psychological and 
social factors in 
the pathogenesis 
and prognosis of 
AA in childhood  
Methodology: Quantitative  
Design: Not reported  
Measures: 1) CBCL,  2) Coddington 
Life Event Scale, 3) Physical 
examination and blood tests 
 
 
 
 
 
Sampling Method: Not reported  
Recruitment: Outpatient dermatology  
Participants: n=17 AA/AT group (11 
male, 6 female, age range 4-21).  
n=15 AD “Reference group”  (7 male, 8 
female, age range 5-16) 
1) AA Group scores were significantly lower on 
social competence measure than normative 
values (t= -2.35, p <.05)* 
2) 75% of AA group scored below the cut off 
score for clinical psychopathology.  
3) No significant difference in number of life 
events between AA group  and normative values 
(data not provided)* 
44% 
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Author, Date, 
Location 
Aim Methodology and Method of data 
collection 
Participant Information and Sampling 
Method 
Main Findings 
 
Quality 
Assessment 
Score 
Diaz-Atienza 
& Gurpegui, 
2011 
 
Location: 
Spain  
 
To investigate 
environmental 
conditions,  
subjective and 
physiological 
state of AA 
children 
Methodology: Quantitative 
Design: Case Control  
Measures: 1) Clinical interview, 2) 
CDI, 3) STAI, 4) Scale of Life Events, 5) 
Personality questionnaire, 6) FES, 7) 
Blood and urine samples 
Sampling method: Not discussed 
Recruitment: Outpatient dermatology, 
neuropediatric and neurology clinic  
Participants: age range 7-19 years.  
n=31 AA (AT/AU) Group (16 male 15 
female), n=23 Control Group 
1(epilepsy), n=25 Control group 2: 
(healthy siblings)  
1) No significant difference in personality 
variables*, state F(2,76)= 0.28, p=.75, trait 
anxiety F(2,76)= 1.28, p=.28, depression scores  
F(2,76)=0.24, p=.98 between AA and control 
groups 
2)  AA families had more environmental factors 
than control group 1 (χ2(1)=4.23, p=.04) and 
more stressful life events prior onset of alopecia 
61% 
Elkin, Hiker & 
Drabman, 
2006 
 
Location: USA 
To explore 
behavioural 
intervention with 
a child with 
anxiety and AA  
Methodology: Quantitative  
Design: Case Report  
Measures: 1) CDI, 2) RCADS, 3) CBCL 
 
 
Sampling: Not reported 
Recruitment: Psychology CAMHS  
Participant: n=1, 13 year old female 
with AA.  
 
1) Parent and child scores within normal range 
(only raw scores provided)* 
2) Mother reported higher perceived child 
anxiety than participant 
3) Results support use of behavioural techniques 
for anxiety arising from the onset of AA 
42% 
Farajzadeh et 
al, 2013 
 
Location: Iran 
 
To evaluate the 
clinical profile of 
AA in children 
 
 
Methodology: Quantitative  
Design:  Cross Sectional Survey 
Measures: 1) SALT, 2) Physical 
assessment, 3) Clinical Interview   
Sampling Method: Not reported  
Recruitment: Paediatric dermatology 
Participants: N=100 (57 males, 43 
females) with AA/AT. Age range 1-16 
years 
1) 33% reported stress prior to onset of AA  
2) Age of onset, socioeconomic and parent 
educational status significantly associated with 
severity of young person’s hair loss. (p<.05)* 
78% 
Ghanizadeh, 
2008 
 
Location: Iran  
 
To understand 
the prevalence of 
lifetime comorbid 
psychiatric 
disorders in AA.  
Methodology: Quantitative  
Design: Survey  
Measures 1) Standardised clinical 
interview 2) Psychiatric assessment  
 
Sampling: Not reported 
Recruitment: CAMHS inpatient  
Participants: N=14 with AA, mean age, 
11.66 years (age range not reported) 
 
1) 78% had one or more lifetime psychiatric 
disorders. Depression most frequent disorder 
(50%).  
2) 71% met DSM-IV criteria for current 
psychiatric diagnosis. 
44% 
Hankinson, 
McMillan,  
Miller, 2013 
 
Location: USA 
 
Explore the 
perception and 
attitudes of 
children towards 
AA  
 
Methodology: Quantitative  
Design: Not reported 
Measures 1) Research Interview, 2) 
Observation of behaviour 
 
Sampling: Not reported 
Recruitment: Not reported  
Participants: N=123 aged 5-14yers 
 
 
1) 42% young children (5-9 years) and 54% older 
children (10-14 years) perceived AA child was 
sick, dying or contagious.   
2) Children (5-9 years) interviewed in pairs were 
five times more likely to feel scared to form a 
relationship with a peer with alopecia compared 
to older children (10-14 years) 
31% 
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Author, Date, 
Location 
Aim Methodology and Method of data 
collection 
Participant Information and 
Sampling Method 
Main Findings 
 
Quality 
Assessment 
Score 
Karambetsos, 
et al, 2013  
 
Location: 
Greece 
 
 
To assess mental 
health of children 
with AA and AD 
reported by 
parents.  
Methodology: Quantitative  
Design: Cross Sectional Survey  
Measures: 1) CBCL, 2) Symptom 
Checklist-90-Revised (SCL-90-R), 3) 
Clinical Interview  
Sampling: Not reported 
Recruitment: Outpatient Dermatology  
Participants:  
n= 51 Parents of children with AA (6-
14 years)  
n = 14 Parents of children with AD (6-
14 years)  
n= 12 Control group   
1) Anxiety, depression and social problem scores 
significantly higher in AA group compared to 
control group (p<.01)* 
2) Maternal education status was significantly 
lower in AA group than control group (p<.01)*  
69% 
Liakopoulou, et 
al., 1997 
 
Location: 
Greece 
 
To investigate 
psychopathology, 
QOL, frequency of 
life events in 
children with AA  
Methodology: Quantitative  
Design: Not reported  
Measures 1) The Child Psychiatric 
Interview, 2)CBCL , 3) CMAS, 4) CDI, 
5) LES  
 
 
Sampling Method: Not reported   
Recruitment: Outpatient dermatology 
and paediatric clinic  
n=33 AA Group 1 mean age 10.5 years 
n=16 AA Group 2 mean age 4.6 years  
n=30 Control Group 1 mean age 10.6 
years  
n=16 Control Group 2 mean age 4.2 
years 
1) Parents of AA groups scored their children 
significantly higher scores on anxious/depressed 
subscale of CBCL than parents of control groups 
(F(1.59) = 49.04, p<0.01) 
2) No significant difference in CDI depression 
scores between AA group 1 and control group 
(z= 1.1248, p=.26)* 
3) AA group 1 scored significantly higher on 4 
anxiety subscales compared to control group 
(p<0.05)* 
4) No significant difference in number of 
negative life events between AA Group 1 and 2 
and control groups (χ2 (1)= 2.97, p=.08) 
61% 
(k=0.82) 
Manolache,  
Petrescu-
Seceleanu, & 
Benea,2008 
 
Location: 
Bucharest 
 
To examine 
relationship 
between AA and 
stressful events in 
children 
 
 
Methodology: Quantitative 
Design:  Case Control Design 
Measures: Clinical interview  
Sampling Method: Not reported.   
Recruitment: Dermatology 
department 
Participants: N=86, <14 years old 
n= 43 AA Group (18 males, 25 
females).  
n=43 Control Group (other skin 
conditions)   
1) Mean AA group scores on stressful events 
prior to AA onset was significantly higher 
compared to control group (χ2 =-14.36, p<.01)*, 
OR 7.14(95%CI, 2.59-19.63). 
2) 88% of participants with AA reported a single 
stressful event  
28% 
Mehlman & 
Griesemer,1968 
 
Location: USA 
 
To investigate 
relationship 
between child AA 
and emotional 
state.    
Methodology: 
Qualitative/Descriptive  
Design: Case Report 
Measures: Clinical Psychiatric 
Interview  
Sampling: Not reported 
Recruitment: Outpatient Paediatric 
clinic 
Participants: N=20 AA, AT, AU (7 
male, 9 female, age range 2.5-18) * 
1) Traumatic weaning, abandonment, “neurotic 
anxiety”, birth of sibling and loss occurred two 
weeks prior to AA onset   
 
33% 
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Author, Date, 
Location 
Aim Methodology and Method of data 
collection 
Participant Information and 
Sampling Method 
Main Findings 
 
Quality 
Assessment 
Score 
Rafique & Hunt, 
2015  
 
Location: 
Pakistan 
 
To understand 
adolescent’s 
experiences of 
living with AA   
Methodology: Qualitative, 
Interpretative Phenomenological 
Analysis (IPA)  
Method: Semi structured interviews  
 
Sample method: Not reported 
Recruitment: Outpatient dermatology   
Participants: N=8 (3 male, 5 female, 
age range 16-19).  
n=3 developed interview schedule 
and included in analysis.   
1) 4 super ordinate themes, 16 subordinate 
themes. Super ordinate themes: 1) Loss, 2) 
Concerns, 3) Negative (emotions/thoughts), 4) 
Coping styles 
2) Males and females expressed different coping 
behaviour 
86% 
 
(k=0.85) 
Reeve, Savage 
& Bernstein, 
1996 
 
Location: USA  
 
To identify 
psychiatric 
diagnoses and life 
stressors in 
children with AA  
 
Methodology: Quantitative 
Design: Cross Sectional Survey 
Measures: 1) Standardised clinical 
Interview, 2) RCAMS, 3) CDS,  4) 
LECL, 5) CDRS-R, 6) Piers-Harris 
Children’s Self-Concept Scale 
7) FES, 8) CBCL, 9) SCL-90-R 
Sampling method: Not reported 
Recruitment: Outpatient dermatology  
Participants: N=12 with AA, age range 
6-14 years. Sex distribution not 
reported.  
 
1) n=7 met diagnostic criteria for anxiety in 
clinical interview  
2) Group mean scores were in the non-clinical 
range for depression (M=26, SD=7.6) and anxiety 
(M=62, SD=6.4) 
3) Group mean self-concept scale score (T=64.6) 
indicated a high positive self-concept (93rd 
percentile) and above the normative value. 
56% 
 
(k=0.82) 
Toback & 
Rajkumar, 1979 
 
Location: USA 
 
To assess the 
“psychodynamics” 
in children with 
AA, AT and 
trichotillomania  
 
Methodology: Quantitative  
Design: Not reported   
Measures: 1) Wechsler Intelligence 
Scale, 2) Geometric forms test, 3) 
Goodenough draw a man test, 4) 
Bender gestalt test, 5) Picture 
vocabulary test, 6) Clinical Interview  
Sampling method: Not reported 
Recruitment: Paediatric Ambulatory 
service 
Participants:N=15 (9 male, 6 female, 
age range 3-12)   
n=8  AA Group  
n=2 AT Group  
n=5 Trichotillomania Group 
1) AA group:  n=3 “moderate emotional 
disturbance”, n=5 “mild emotional disturbance” 
2) AT group: n=1 “moderate emotional 
disturbance”, n=1 “severe emotional 
disturbance”  
 
25% 
 
(k=0.79) 
Wolf, 2014 
 
Location: USA 
 
To explore factors 
that impact young 
people with AA 
and use of coping 
strategies  
 
Methodology: 
Quantitative/Qualitative 
Design: Mixed methods  
Measures 1) Survey Questionnaire 
(created by the researcher), 2) Semi 
Structured Interview 
Sampling Method: Purposeful  
Recruitment: Charity database, social 
media, websites & conventions 
Participants:  
Quantitative: N=237 with AA (77 
male, 160 female, age range 10-19)  
Qualitative: N=11 with AA (6 male, 7 
female age range 12-18)  
Quantitative: Impact factors associated with AA 
1) self-esteem, 2) psychological effects, 3) 
appearance/acceptance, 4) socialization, 5) 
communication  
Coping strategies associated with AA: 1) 
physiological, 2) avoidance, 3) outside support, 
4) social support   
Qualitative: 3 main themes: 1) Acceptance, 2) 
Social issues 3) Coping 
44% 
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1.3.1 Findings  
1.3.1.1 Aim: What are the psychosocial factors associated with the onset of 
alopecia in children and young people? 
Out of the 19 papers included in the review, a total of 7 studies explored the 
psychosocial factors associated with the onset of alopecia. Within these papers, 
the presence of relational, social factors and the frequency of events emerged as 
key themes.  
 
1.3.1.1.1 Relational and Social Factors 
In a descriptive study exploring psychosocial factors for young people with 
alopecia aged 5-16 years, 81%, of parents and children reported a relational 
difficulty to have occurred within six months prior to the development of alopecia 
(Andreoli et al., 2002). The majority of these difficulties centred on experiencing 
the separation from important attachment figures, separation anxiety and 
relationship discord within the family and school systems (Andreoli et al., 2002). 
The researchers concluded difficulties within the family system were more likely 
to occur during the pre-alopecia phase compared to events that are commonly 
associated with stress, such as the birth of a sibling and beginning of school. The 
loss of attachment, emotional security and family discord prior to the 
development of alopecia is also reiterated in the findings of other papers 
(Mehlman & Griesmer, 1968). However, in contrast, common stressful events in 
childhood such as traumatic weaning and birth of siblings were considered to be 
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important life events that occurred during the pre-alopecia phase (Mehlman & 
Griesmer, 1968). Drawing upon their findings within their clinical practice, the 
researchers hypothesised that rather than the type of relational difficulty, the 
association with the onset of alopecia is likely to be dependent on the child’s 
subjective perception of a situation and whether it poses a threat to their 
emotional wellbeing (Mehlman & Griesmer, 1968). Although Andreoli et al (2002) 
and Mehlman and Griesmer (1968) make reference to a possible association 
between relationship difficulties and alopecia, they do not include a comparative 
control group, with the method of data collection focused on the use of 
unstructured interviews and observations in clinical practice. As highlighted in the 
quality assessment scores of these studies, they did not employ a control group 
or conduct a statistical analysis on the findings and as such, it is difficult to draw 
any firm conclusions in relation to the strength of the observed association.  
 
The association between the subjective state of young people with alopecia and 
environmental stressors within the family system has also been explored using 
case control designs. Research completed by Diaz-Atienza and Gurpegui (2011) 
found children (aged 7-19 years) with alopecia had significantly more 
environmental stressors (χ2(1)=4.23, p=.04) than age and sex matched control 
group of children with epilepsy. With an odds ratio of 7.6 [95%CI, 1.5-38.2] 
children with alopecia reported more family conflict and separation from an 
attachment figure (migration, marital separation and death) (Diaz-Atienza & 
Gurpegui, 2011). Furthermore, compared to the control group, families of a child 
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with alopecia were significantly less expressive of their emotions, indicative of 
alexithymia traits (χ2(1)= 4.20, p=.04) (Diaz-Atienza & Gurpegui, 2011).  Whilst the 
power of the results are questionable due to the sample size of participant 
groups (Diaz-Atienza & Gurpegui, 2011), in light of the method of data analysis 
and use of a control group, it could be hypothesised the lack of emotional 
expression between family members and separation from an attachment figure 
could influence how the family system responds to and manages stressful 
situations. These findings highlight the importance of considering the difficulties 
within the family and social systems during the pre alopecia phase, rather than 
limiting the focus to just individual factors.  
 
Similar to Diaz-Atienza and Gurpegui (2011) findings, research completed by 
Manolache, Petrescu-Seceleanu and Benea (2009)  found a significant difference 
in the number of relational and social factors experienced by young people in the 
pre alopecia phase compared to control groups (χ2 =-14.36, p<.01). The odds ratio 
indicated children with alopecia below the age of 14 years were seven times 
more likely to experience social and relational difficulties, compared to children 
in the control group who only reported the presence of social factors. The most 
common stressful trigger reported by all participants was in relation to starting 
school and changes at school. However, children with alopecia also reported 
family problems such as trauma, financial worries and family disputes 
(Manolache et al., 2009). As reflected in the quality assessment score (28%), the 
limited information provided on the population sample and method of data 
collection restricts the ability to understand the observed differences between 
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participants with alopecia and the control group. However, one hypothesis may 
be the accumulation of difficulties at school and within the family that may be 
important factors.  
 
1.3.1.1.2 Frequency of life events  
The findings into the number of negative and stressful events in the pre alopecia 
phase are mixed, with some studies reporting a single stressful event whilst 
others report the occurrence of multiple events (Andreoli et al., 2002; Diaz-
Atienza & Gurpegui, 2011; Farajzadeh et al., 2013; Manolache, et al., 2009). 
Research completed by Andreoli et al (2002), concluded it is the duration of a 
single event during the pre alopecia phase that is important, rather than the 
number of stressful events. In contrast to these findings, other papers allude to 
the presence of multiple stressful events with parents of young people of 
alopecia reporting a significantly higher number of stressful events during the pre 
alopecia phase compared to control groups H(2)=23.11, p<.001) (Diaz-Atienza & 
Gurpegui, 2011). Furthermore, other studies have not found a significant 
difference in the number of negative life events between young people with 
alopecia, control groups and normative data for life events scales (De Waard-Van 
Der Spek, Raeymaecker, Koot & Oranje 1994; Liakpoulou et al., 1997). However, 
unlike the other papers included in the review, research completed by Liakpoulou 
et al (1997) found children with alopecia significantly reported fewer positive life 
events (χ2(1)= 6.23, p=.01) than control groups prior to the onset of alopecia. 
These findings are suggestive of the need to focus not only on the frequency of 
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the negative life events within the family system, but also on the presence of 
positive events in order to support the psychosocial understanding in the onset of 
alopecia in young people.   
 
1.3.1.1.3 Summary  
Overall, quality research into the psychosocial factors associated with the onset 
of alopecia in young people is limited, with over half of the papers (n=4) receiving 
a poor quality assessment score (<50%). In particular, the methodological 
limitations associated with the use of small sample sizes and descriptive analysis, 
(Barker, Pistrang & Elliott, 2015) could impact the power and validity of the 
findings and increase the possibility of a Type II error occurring.  As highlighted in 
Table 1.3, several methods of data collection are used in the papers including the 
use of self-report measures and non-standardised clinical interviews. As the 
method of data collection can influence what information is obtained, it can 
make it difficult to compare findings across studies which use various techniques 
to collect participant data (Wethington, Brown & Kessler, 1995). The reliance on 
interviews and inconsistent definition of a psychosocial factor, are also likely to 
increase possible researcher bias in the method of data collection. Furthermore, 
it could increase the subjectivity in the interpretation of participant information 
and rigour of analysis in the data that is collected.  
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One of the main considerations of these papers is the reliance on retrospective 
data which is likely to have been impacted by the varying length of time between 
the onset of alopecia for participants and date the study was completed. It is 
possible participants recall of events was biased, which could impact the overall 
findings of the papers. Regardless of these methodological limitations, overall, 
the findings indicate a number of psychosocial factors could be associated with 
the onset of alopecia. In particular, social situations commonly associated with 
stress and difficulties in the family system, such as loss of attachment, may signal 
a threat to a young person’s emotional wellbeing. The duration of a negative life 
event, how families express their emotional state and lack of positive events may 
also be important factors to consider. The pathogenesis of alopecia in young 
people is complex and this is reflected in the mixed results of the papers. It is 
therefore important to consider these psychosocial factors in context of the 
biological and environmental factors that could trigger the onset of alopecia in 
young people.  
 
1.3.1.2 Aim: What are the psychosocial factors associated with living with 
alopecia for children and young people?   
Within the 19 papers included in the review, a total of 16 studies explored the 
psychosocial factors associated with living with alopecia for young people. Four 
key themes emerged from the literature: 1) mental health difficulties (depression 
and anxiety) 2) self-esteem and quality of life, 3) social factors, 4) psychosocial 
intervention and coping strategies.   
32 
 
 
1.3.1.2.1 Depression 
For some papers in the review, mental health difficulties were associated with 
children living with alopecia. In particular, parents of children with alopecia 
scored their children to have significantly higher levels of depression, anxiety and 
somatic complaints compared to parents of children with atopic dermatitis and 
the control group (p=<.01) (Karambetsos et al., 2013). Furthermore, research 
completed by Ghanizadeh (2008) reported half of children with alopecia who met 
the criteria for a psychiatric disorder had a major depressive disorder. However, 
for other papers, a significant association between depression and young people 
living with alopecia was not found (Al-Okali, El-Shourbagy & Wassif, 2008; Bilgic 
et al., 2014; Diaz-Atienza & Gurpegui, 2011). Whilst the findings into the 
association between depression and young people living with alopecia is mixed, it 
is possible these inconsistencies result from children and parent’s perspectives 
being analysed separately or combined in the same results. This is highlighted in 
the research completed by Liakpoulou et al (1997) where they found parents 
scored their child with alopecia to have significantly higher scores on the 
anxious/depressed subscale, compared to parents in the control groups (F(1.59)= 
49.04, p<0.01). However, separate analysis of the measures completed by young 
people indicated that depression scores were not significantly different compared 
to those of the control group (z=1.1248, p=.26). 
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1.3.1.2.2 Anxiety 
The majority of the papers in the review found an association between anxiety 
and young people living with alopecia, with significantly higher anxiety scores 
reported by both young people with alopecia and their parents compared to 
control groups (Al-Okali et al., 2008; Liakpoulou et al., 1997). Furthermore, 
research that separated data from child and adolescent participants found state 
(t=3.16, p<.001) and trait (t=2.95, p <.001) anxiety to be significantly higher for 
children (8-12 years) compared to scores provided by the control group (Bilgic et 
al., 2014). However, for adolescents, (13-18 years) only state anxiety scores were 
significantly higher compared to the age matched control group (t=4.04, p<.001)  
(Bilgic et al., 2014). The findings from the qualitative research included in the 
review supplements quantitative results as participants reported experiencing 
anxiety towards future concerns, self-identity and appearance (Rafique & Hunt, 
2015). 
 
Not all of the papers included in the review draw the same conclusions, with 
some studies reporting mixed findings (De Waard-Van Der Spek et al., 1994). For 
example Reeve, Savage and Bernstein (1996) found anxiety scores to be within 
normative range on self-report measures that were completed by participants. 
However, in structured interviews with the same participants and their parents, 7 
out of the 12 participants met the diagnostic criteria for anxiety disorders (Reeve 
et al., 1996). Whilst Reeve et al (1996) concluded this discrepancy highlighted the 
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child’s minimization of their difficulties and the parent’s ability to over identify 
anxiety in their child, due to the small sample size (N=12) and lack of statistical 
analysis, it questions the credibility of the findings. Other research into anxiety 
has also shown no significant difference in anxiety scores between children with 
alopecia, epilepsy and ‘healthy’ sibling control groups (Diaz-Atienza & Gurpegui, 
2011). However, as the researchers also found young people with alopecia 
showed biological markers of stress (increased sympathetic tone), they concluded 
participants could have “dissociated from conscious experience” of their physical 
state (Diaz-Atienza & Gurpegui, 2011, p.106). Whilst this could account for the 
differences in the findings across the papers, the researchers also reiterated 
participant’s use of medication and medical treatment could be confounding 
variables that were not accounted for (Diaz-Atienza & Gurpegui, 2011).  
 
1.3.1.2.3 Self-esteem and quality of life  
The earliest paper to be published that is included in the review found young 
people with alopecia had a “mild-moderate emotional disturbance” due to a 
“poor adjustment” at home and at school (Toback & Raikumar, 1979, p.115-116). 
A case report also reported similar findings for a young male who had difficulties 
with school, low self-esteem and stress (Coulacoglou, Tchinou & Michpoulou, 
2001).  Although the results of these papers should be held in context of their 
quality assessment scores (25% and 17% retrospectively), research with more 
rigorous methodology also found adolescents living with alopecia experienced 
difficulties with self-esteem (Rafique & Hunt, 2015). The qualitative methodology 
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of this paper enabled participants to report the context surrounding their low 
self-esteem, which included difficulties associated with identity formation, 
concerns about the future and themes associated with loss (Rafique & Hunt, 
2015). Whilst these results indicate self-esteem is an important factor to 
consider, research completed by Reeve et al (1996) found the self-esteem scores 
for participants with alopecia were above the normative value (93rd percentile) 
and thus, indicated a high positive self-concept. Furthermore, research 
completed by Wolf (2014) found the scores provided by children with alopecia for 
confidence and self-esteem was significantly higher (F(2,234)=12.076, p<.001) than 
the scores provided by adolescent participants.  
 
Only two studies explored quality of life. These papers reported that parents 
perceived alopecia to have a greater detrimental effect on their child’s quality of 
life compared to the scores provided by their child (Beattie & Lewis-Jones, 2006; 
Bilgic et al, 2014). This discrepancy between child and parent perspective was 
found to be more prominent for children aged eight to twelve years compared to 
the quality of life scores provided by parents and adolescents (Bilgic et al, 2014). 
However, some consistency between parent and young people’s perspectives 
was found. This occurred in questions related to the frequency of bullying and 
teasing, as both the young person and their parent rated this to be an area of 
concern (Beattie & Lewis-Jones, 2006). The findings of these two papers provide a 
preliminary understanding of quality of life for young people with alopecia. As 
highlighted by Beattie and Jones, (2006) quality of life measures commonly 
include questions about family and peer relationships and as such, the presence 
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of social factors should also be considered in order to gain a holistic 
understanding of the quality of life for young people (Beattie & Lewis-Jones, 
2006). 
 
1.3.1.2.4 Social factors  
Although research into the social factors related to alopecia is limited, the social 
competence (e.g. social relationships, school performance) scores of young 
people was found to be significantly lower the expected normative value (t=-2.35, 
p<.05) (De Waard-Van Der Spek et al., 1994). Hankinson, McMillan and Miller 
(2013) also explored social relationships from the view of children between the 
ages of 5-14 years without alopecia. The authors found nearly half of participants 
thought a child with alopecia was contagious or sick (Hankinson et al., 2013). 
Furthermore, compared to older children (10-14 years), young children (5-9 
years) interviewed in pairs were five times more likely to be fearful of developing 
a relationship with a child who had alopecia (Hankinson et al., 2013). Whilst the 
findings of these papers should be considered in context of their quality score 
(44%, 31% respectively), they suggest the perception of alopecia within a young 
person’s peer group could shape the opportunities available for social skill 
development.  
 
The demographic information of families living with alopecia was also considered 
as a social factor related to young people living with the condition. Families who 
participated in research tended to be from low socio-economic groups with 
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parents having a lower education status (Farajzadeh et al., 2013; Karambetsos et 
al., 2013; Reeve et al., 1996). As well as the demographic information, parents’ 
mental health was also explored within the literature. Findings are mixed, with 
some papers reporting the presence of depression for parents (Elkin, Hiker & 
Drabman, 2006; Karambetsos et al., 2013) and other papers finding a non-
significant relationship (Farajzadeh et al., 2013; Reeve et al., 1996). Despite the 
limited number of papers, the findings highlight the importance of exploring 
wider systemic factors, as they are likely to impact on the availability of social 
support and the types of coping strategies employed by young people living with 
alopecia.   
  
1.3.1.2.5 Psychosocial intervention and coping strategies 
Qualitative research exploring coping strategies found young people used 
practical and ‘action-orientated’ ways of coping with alopecia (Rafique & Hunt, 
2015; Wolf, 2014). This included the use of homemade remedies, wearing 
hats/scarfs as well as self-distraction, use of humour and drawing strength from 
religion and social relationships (Rafique & Hunt, 2015). Both papers reported sex 
differences in coping behaviours, with males employing the use of humour and 
females tending to use self-distraction (Rafique & Hunt, 2015). Wolf (2014) 
concluded the findings of the differences in coping behaviours indicated female 
participants experienced more difficulty in living with alopecia compared to male 
participants. However, as the paper completed by Wolf (2014) was sourced from 
grey literature, it has not been subjected to a peer review. As such, the findings 
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should be considered in light of this as well as the existence of heterogeneity 
within the participant sample.  
 
Only one study explored psychosocial interventions for young people with 
alopecia. Based on the findings of this case report, Elkin et al (2006) concluded 
the use of a behavioural intervention was an effective method for supporting 
anxiety arising from the onset of alopecia. However, in light of the chosen 
methodology, the quality assessment score (42%) and lack of statistical analysis, 
questions the validity and generalisability of their findings.  
 
1.3.1.2.6 Summary 
Overall, the findings of the review indicate anxiety is an important factor for 
young people living with alopecia. Whilst the results were mixed, quality of life, 
self-esteem and systemic difficulties were also highlighted as possible factors 
associated with the condition. Within the papers, a disparity was found in the 
perception of mental health difficulties and quality of life between young people 
and their parent’s. Liakpoulou et al (1997) and Reeve et al (1996) concluded this 
reflected the differences in coping with the impact of alopecia, with children 
using minimisation and parents trying to seek additional support. However, based 
on the findings of Bilgic et al (2014) the differences found between parent, child 
and adolescent scores indicates puberty may influence the experience of 
psychosocial factors for young people. However, it is difficult to generalise and 
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compare the findings across the papers as the variety of measures used differed 
in their psychometric properties, reliability and validity.  
 
The quality of the papers that explored the psychosocial factors related to living 
with alopecia in young people are mixed, ranging from 17-86%. As highlighted 
within the quality assessment framework (see Appendix D), the main difficulties 
included the limited justification of the chosen methodology and lack of adequate 
information relating to data collection, sampling strategy and population sample. 
Without this information, it is unclear if the recruitment process was 
compromised by a selection bias and whether the participant sample was 
representative of the population. Furthermore, of the papers that used 
quantitative methodologies, 13 studies did not use age and gender matched 
control groups. As such, it questions the internal validity of their findings (Barker 
et al., 2015).   
 
1.4 Discussion  
The aim of this review was to explore and critically appraise the literature that 
explored psychosocial factors associated with alopecia in children and young 
people. The papers report mixed findings. However, relational difficulties and the 
experience of emotionally difficult life events maybe important factors to 
consider in the onset of alopecia in young people. An association between anxiety 
and living with alopecia for young people was found in a number (n=7) of papers 
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included in the review. The strength of this association varied across the findings 
and methods of data collection. Other psychosocial factors that were reported 
included poor health related quality of life, difficulties with social competence, 
family and peer relationships and parental socio-economic and mental health 
status. Although the findings highlight research into the coping strategies and 
psychological interventions for young people with alopecia is limited, some 
differences in coping strategies were found between males and females.  
 
Within the review, no studies were conducted with young people with cicatricial 
or androgenetic alopecia.  This is likely to reflect the predominant focus towards 
alopecia areata in adult literature and the complexities associated with the 
pathogenesis of scarring alopecia. Although children and young people can 
develop cicatricial alopecia and androgenetic alopecia, (Gonzalez, Cantatore-
Francis & Orlow, 2010; Ross, Tan & Shapiro, 2005), the current findings within the 
literature are unable to address the possible psychosocial factors related to these 
types of alopecia for children and adolescents. 
 
Some of the findings of the current review mirror research completed within the 
adult population. In particular, research into the presence of alexithymia 
personality traits and stressful life events during the pre-alopecia phase in adults 
has also reported mixed findings (Gulec, Tanrierdi, Duru, Saray & Akcali, 2004; 
Manolache & Bearea, 2007; Picardi et al., 2003). Furthermore, previous 
systematic reviews have also indicated a number of personal, social functioning 
41 
 
factors for adults living with alopecia (Hunt & McHale, 2005a; Liu et al., 2016; 
Tucker, 2009).  
 
Previous research has highlighted that the age alopecia develops can determine 
the severity and longevity of the condition (Fricke & Miteva, 2015). Although the 
findings in the current review are mixed, they also suggest the age of onset is 
associated with the parents’ perception of their child’s mental wellbeing. 
Furthermore, the divergence that was found between child and parental quality 
of life scores was greater on subjective domains compared to more objective 
factors such as the frequency of bullying and teasing by others (Beattie & Jones, 
2006).  As such, it is likely these differences reflect the tension between the 
parents’ anxieties about their child’s future and the child’s desire to keep their 
internal experiences private “in a quest for normality” (Baca, Vickrey, Hays, 
Vassar & Berg, 2010; Verhey, Kulik, Ronen & Streiner, 2009:409). 
 
The findings of the current review are in contrast to research completed by Chu 
et al (2011) who found young people living with alopecia (aged below 20 years) 
were more likely to develop major depressive disorder and for people aged 
between 20 and 59 years, they were more likely to develop anxiety compared to 
the population sample. As their study was completed with Taiwanese participants 
recruited from a national database, the differences in the findings compared to 
the current review could result from the different population samples and 
method of participant recruitment.  
42 
 
 
1.4.1 Limitations of the review 
There are a number of limitations to the review. During the database search, 
three studies whose full text was not available in English were excluded. Whilst 
this may have omitted valuable data from the review, research suggests the 
exclusion of a small number of non-English papers is unlikely to alter the overall 
results of literature reviews (Juni et al., 2002). As such, it was felt the possibility of 
language bias did not influence the overall findings.   
 
As the majority of the research employed quantitative methodologies, a meta-
analysis was originally considered as a possible review of the literature to 
increase the generalisability of the findings.  However due to the lack of 
homogeneity in sample population and the variety of measures that were used, 
the papers did not meet the required criteria.  
 
The varying ages of participant samples used in research was also seen to limit 
the review as several studies were excluded based on the inability to separate 
young people’s data from adult participants. Despite this limitation, it was felt the 
inclusion of these studies would have added adult data into the results, increasing 
the confounding variables in the findings.   
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1.4.2 Research Implications  
Research in this area has used a broad range of participant and population 
samples which indicates people living with alopecia are assumed to be a 
homogenous group. However, based on the findings of the current review, future 
research would benefit from separating children and adolescents into separate 
groups. To enrich the understanding of young people’s experiences, parents 
perspectives towards the psychosocial factors associated with their child should 
also be sought separately from the young person.   
 
As highlighted in the review, future research would benefit from recruiting age 
and gender matched control groups, as well as providing an operational 
definition of the psychosocial factors that are explored. Information on the 
sampling method and population sample is also recommended to increase the 
validity and generalisability of future research.  
 
The majority of the studies within the review focused on the use of quantitative 
methodology. However, this can limit the data that is collected about people’s 
experiences (Yardley, 2000). The use of qualitative methodology could 
supplement the existing quantitative literature and enrich the understanding of 
the psychosocial factors related to the onset as well as living with alopecia.  
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Research in this area has predominately focused on alopecia areata. Future 
research would benefit from exploring psychosocial factors associated with other 
forms of alopecia in young people such as cicatricial and androgenetic alopecia. 
Furthermore, additional research is required into the use of coping strategies and 
psychological interventions. This would provide clinicians and healthcare 
professionals with a better understanding in how to support young people and 
their families with the experience of living with a visible difference.  
 
1.4.3 Clinical Implications  
To support the effectiveness of medical treatment and intervention, it is 
important for clinicians to explore the psychosocial factors that may be present 
for young people with alopecia and the effect the condition could have on the 
family system. More specifically, the use of routine, validated screening tools or 
outcome measures for both the parent and young person with alopecia could be 
helpful in understanding their perspectives towards current difficulties and 
whether any differences exist between the difficulties that are reported by the 
parent and young person.  Furthermore, it may provide additional insight into 
where psychological support should be focused, in terms of working with a young 
person directly, their parents or to address wider systemic issues.  
 
Whilst only one paper explored psychosocial interventions, the range of factors 
highlighted within the review indicates the need for clinicians to adopt a holistic 
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approach to supporting young people living with alopecia. More specifically, the 
findings suggest the importance for clinical psychologists to consider the use of 
systemic ways of working to ensure the perspective of the child, their parents and 
the wider psychosocial factors are considered within a young persons’ 
formulation and therapeutic intervention.  
As the papers in the review used a broad range of outcome measures to explore 
psychosocial factors, it suggests there is no single measure that is recommended 
for young people with alopecia.  However, clinicians may wish to consider the 
Revised Child Anxiety and Depression Scale (RCADS child and parent version) and 
the children’s dermatology life quality index (CDLQI). These measures are 
considered to have appropriate psychometric properties for use with children, 
adolescents and their families and are widely used within research and services 
supporting young people (Chorpita, Ebesutani & Spence, 2015; Ebesutani, 
Bernstein, Nakamura, Chorpita & Weisz, 2010; Olsen, Gallacher, Finlay, Piguet & 
Francis, 2016).  
 
Although NICE guidelines advocates clinicians to consider the psychosocial needs 
of people with alopecia (NICE, 2014b), they are limited in addressing how 
clinicians such as consultant dermatologists and general practitioners should 
approach conversations about mental health with service users. This can be a 
particularly challenging conversation for clinicians to have with clients in the 
context of the time they are commissioned for each appointment (Burns, 
Greenwood, Kendrick & Garland 2000; Gordon-Elliott & Muskin, 2013; McCabe & 
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Leas, 2008). Training, supervision and consultation in communication skills, 
screening for psychological distress and mental health could be beneficial for 
clinicians to develop their skills in exploring young people and their family’s 
mental health. This may be helpful in supporting clinicians to recognise when to 
refer service users to appropriate mental health services for timely support and 
psychological intervention.  
 
1.4.4 Conclusion  
Research indicates psychosocial factors are associated with both the onset and 
living with alopecia for children and young people. The findings highlight the need 
for high quality studies to be completed to enhance the understanding of the 
experiences of young people with alopecia and the generalisability of the 
findings. Clinical implications indicate medical clinicians may benefit from 
additional training, supervision and consultation in order to support the 
psychosocial factors associated with alopecia in young people.  
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2.0 Abstract  
Aim: The psychological understanding of rosacea is limited. Findings from 
quantitative studies indicate women living with the condition can encounter 
various psychological and social difficulties. The aim of the paper is to explore the 
lived experiences of women with rosacea.  
Method: Semi-structured interviews were completed with six adult women with 
rosacea. Interpretative Phenomenological Analysis (IPA) methodology and 
ideologies were employed throughout the development of the research, data 
collection and analysis of participants’ transcripts.  
Results: Two super ordinate themes emerged from the findings: ‘concealment’ 
and ‘it’s a battle, isn’t it’. The experiences of participants was characterised by an 
internal struggle to feel in control of their skin condition, whilst externally 
learning to navigate complex social interactions.  
Conclusion: Within clinical practice, the psychosocial factors associated with 
rosacea need to be considered. Other research and clinical implications are 
discussed.  
Key words: Rosacea, lived experience, women, IPA 
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2.1 Introduction 
2.1.1 Rosacea 
Rosacea is an inflammatory facial skin condition that is estimated to affect 
between 1-20% of the population (Tan & Berg, 2013). Symptoms typically include 
erythema (persistent redness), pustules, telangiectasia (small dilated blood 
vessels), inflammation of the eye lids and phymatous (enlargement of facial 
features) (Starr & Macdonald, 1969; Steinhoff, Schauber & Leyden, 2013). These 
symptoms can cause pain, burning sensations and in severe cases, visual 
impairments (Wilkin et al., 2002). A variety of medical treatments for managing 
rosacea are available, all of which are limited in their effectiveness, with the 
majority only providing temporary symptom reduction.  (Van Zuuren, Fedorowicz, 
Carter, Van der Linden & Charland, 2015). Whilst the etiopathogenesis of the 
condition is relatively unknown, the condition is chronic, causing individuals to 
experience multiple symptoms that can increase in severity over time (Spoendlin, 
Voegel, Jick & Meier, 2012; Wilkin et al., 2002). The lack of clarity regarding the 
condition’s aetiology has meant rosacea symptoms are often mistaken by others 
for signs of alcohol misuse and poor personal hygiene which can lead to 
psychological distress for people living with the condition (Barankin, 2003; Blount 
& Pelletier, 2002).  
 
It is estimated that the majority of people living with rosacea are undiagnosed 
and only seek medical support when they perceive their symptoms to be severe 
or when they have a detrimental effect on mental wellbeing and quality of life 
(Abram, Silm, Maaroos & Oona, 2009; Wehausen, Hill & Feldman, 2016). For 
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clinicians, recognising the psychosocial factors associated with rosacea can be 
challenging as the objective severity of a visible difference does not correlate 
with the lived experience (Clarke, 1999). This has meant psychosocial factors 
related to rosacea can be overlooked within professional practice (Huynh, 2013).  
 
2.1.2 Psychosocial factors associated with rosacea  
Although the findings are limited, quantitative research has consistently reported 
the presence of anxiety, depression, social difficulties and decreased quality of 
life for participants living with rosacea (Egeberg, Hansen, Gislason & Thyssen, 
2016; Gupta, Gupta, Chen & Johnson, 2005; Moustafa, Lewallen & Feldman, 
2014; Su & Drummond, 2012). A recent systematic review of the literature also 
found rosacea to have a detrimental effect on perceived quality of life (Van Der 
Linden et al., 2015). Within this review, the impact on perceived quality of life 
was more prominent for young people with rosacea and participants with severe 
forms of the condition (Van Der Linden et al., 2015).  
 
As well as individual factors, research into societal perception of rosacea found 
‘healthy’ participants scored faces with erythema as less trustworthy, healthy and 
fun compared to the same face without persistent redness (Dirschka et al., 2015). 
Furthermore, a recent survey found nearly a third of participants reported 
feelings of stigmatisation which included being subjected to rude comments or 
jokes about their skin condition (Halioua, Cribier, Frey & Tan, 2017). These 
feelings of stigmatisation were found to be a mediating factor for anxiety and 
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depression in participants living with rosacea (Bohm, Schwanitz, Gissendanner, 
Schmid-Ott & Schulz, 2014).  
 
The majority of research into the psychosocial factors associated with rosacea has 
employed quantitative methodology and cross sectional survey designs. More 
recently, research has employed qualitative methodologies to analyse unscripted 
comments posted on online support forums. Themes highlighted within their 
findings indicate people living with rosacea wish to seek information about 
medical treatment and support for difficulties associated with depression, 
anxiety, confidence and self-esteem (Alinia et al., 2016; Cardwell, Farhangian, 
Alinia, Kuo & Feldman, 2015). Whilst these papers provide an indication of the 
topics that are important to people with rosacea, the papers do not report details 
on the method of qualitative analysis which can limit the credibility of the 
findings (Yardley, 2000). Moreover, they are unable to provide an in-depth 
account of the lived experience of rosacea due to the chosen method of data 
collection.  
 
2.1.3. Sex differences and rosacea  
Women are two-three times more likely to develop rosacea and are more likely 
to develop the condition at an earlier age compared to men (Wollina, 2011).  
Males who are diagnosed with rosacea usually experience symptoms associated 
with the phymatous subtype which is managed through the use of medication 
and surgical procedures (Powell, 2015; Wollina, 2014). However, in contrast, 
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females typically experience multiple symptoms across different subtypes which 
can be more resistant to medical intervention and harder to treat (Goldgar, 
Keahey & Houchins, 2009; Tisma et al., 2008).  
 
Research into the psychosocial factors associated with rosacea for men and 
women has reported inconsistent findings (Van Der Linden, et al., 2015). Whilst 
one study reported higher levels of depression and lower quality of life for men 
with rosacea (Bohm et al., 2014), other findings indicate women with rosacea 
have a higher risk of depression and anxiety and lower quality of life compared to 
men (Aksoy, Altaykan-Hapa, Egemen, Karagoz & Atakan, 2010; Egeberg et al., 
2016).Whilst it is unclear whether men or women are more likely to be impacted 
by rosacea, the literature indicates possible sex differences in the lived 
experience of the condition. This suggests the inclusion of men and women with 
rosacea in the same group in research studies could increase the heterogeneity of 
the participant sample and thus, indicates the merit of exploring the experiences 
of rosacea from a gender specific focus.  
 
2.1.4. Rationale and aim  
The etiopathogenesis of rosacea is largely unknown. However, a number of 
psychosocial factors have been associated with the condition (Powell, 2005; 
Sowinska-Glugiewicz, Ratajczak-Stefanska & Maleszka, 2004). Research into 
rosacea has employed a range of questionnaires and surveys which vary in their 
reliability, validity and sensitivity (Van der Linden et al., 2015).  It is therefore 
possible the psychological needs of people living with rosacea could be under 
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estimated within the literature. Research has also been conducted on a variety of 
population samples, consisting of different ages, sexes, cultures and clinical 
samples. As such, this can make it difficult to compare research findings (Bessell & 
Moss, 2007).  
 
The use of quantitative methods have dominated research into the psychosocial 
factors associated with rosacea. However, this methodology is unlikely to reflect 
the complexity of the emotions, cognitions and overall experiences associated with 
living with visible differences (Collins & Nicolson, 2002; Thompson & Kent, 2001). 
A phenomenological, idiographic approach to explore the subjective experience of 
a homogenous sample of participants with rosacea could help address this gap 
within the literature as it provides an in-depth account of lived experience that 
quantitative measures are unable to address (Brocki & Wearden, 2006). The 
research aims to provide an exploratory account of the experiences of women 
living with rosacea. In particular, the research aims to gain an understanding of the 
lived experience of visible difference, conceptualisation of rosacea and the process 
of receiving a clinical diagnosis and treatment. These aspects merit particular 
consideration as they are clinically salient and could potentially be important to 
understanding the lived experience of women with rosacea.  
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2.2 Methods  
2.2.1 Research Design 
In accordance with the research aims, a qualitative methodology was chosen. 
Interpretative Phenomenological Analysis (IPA) was selected due to its focus on 
exploring participants’ experiences, cognitions and how they make sense of their 
world (Larkin, Watts & Clifton, 2006). IPA is considered to be an effective 
approach in understanding the subjective experience of physical health 
conditions and is widely used within health psychology research (Brocki & 
Wearden, 2006). The idiographic and hermeneutic ideology that underpins this 
methodological approach provides a balance between understanding the 
meaning attached to personal experience and acknowledging the role of the 
researcher in making sense of an individual’s narrative (Smith, 2004).  
 
2.2.2 Procedure 
2.2.2.1 Ethical Procedures 
A research project proposal was reviewed and approved by Coventry University 
Ethics Committee, NHS Research and Ethics Committee (REC), Health Research 
Authority (HRA) and the local NHS Research and Development Department (See 
Appendices F-I). In addition, the British Psychological Society (BPS) code of ethics 
and conduct (2009), and code of human research ethics (BPS, 2010) were also 
adhered to throughout the research project.   
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2.2.2.2 Materials 
A semi structured interview was employed as they are seen as archetypal method 
of IPA (Smith & Osborn, 2007). One to one interviews were chosen to allow a 
rapport to develop and provide a space for participants to describe their 
experiences and perceptions of their world (Smith, Flowers & Larkin, 2009). The 
interview schedule (see Appendix J) contained eight questions with the use of 
prompts to allow for an exploration of participant experience and intensify the 
richness of the collected data (Smith, 2004). The interview questions were 
developed by exploring themes within the literature relating to other acquired 
facial disfigurements. Discussions with the supervision team also supported this 
process and ensured the interview schedule maintained a degree of flexibility to 
allow participants to express their thoughts and experiences.  
 
2.2.2.3 Recruitment  
Purposive sampling was used in the project. This included service users who were 
accessing support or had done so previously from three identified NHS research 
sites. Service users were initially screened against the inclusion criteria by 
Dermatologists working at the research sites. Dermatologists were chosen as they 
had access to information relating to the inclusion criteria as part of their routine 
clinical contact with clients. Dermatologists discussed the research with service 
users and provided them with a participant information sheet (see Appendix K). 
Clients who wished to register their interest in participating in the project or 
receive additional information were provided with the researcher’s contact details 
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and a consent form (see Appendix L) by the dermatologist. Thirteen people 
provided consent to be contacted by the researcher, after which four people 
declined to participate and three chose not to get back in contact with the 
researcher. A total of six people participated.  
 
2.2.2.4 Interview Procedure 
Prior to the interviews, participants signed a written consent form (see Appendix 
M) and completed a demographic information sheet (see Appendix N). The 
majority of the interviews took place at the research site (n=5) and one took place 
in the participants home (n=1). All interviews were recorded via dictaphone.  
Interview length ranged from 38 minutes to 72 minutes, averaging 57 minutes. 
Following the interview, participants were provided with a debrief information 
sheet (see Appendix O) and opportunity to ask any further questions about the 
research. Participants were also asked if they wished for their General Practitioners 
(GP) to be sent a letter to inform them of their participation in the research project 
(See Appendix P). All participants reported they wished for a copy of the overall 
findings once the research had been completed.   
 
2.2.3 Participants 
Participants who met all the inclusion criteria outlined in Table 2.1 were considered 
for the research project. As highlighted in the table, the age of participants was 
limited to individuals aged 20 years and above in order to capture participants who 
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are representative of the clinical population (Berth-Jones, 2010; Wollina 2011). In 
order to allow sufficient time for participants to have a lived experience of rosacea, 
the criteria of having rosacea for more than six months was included.  
 
Table 2.1: Participant inclusion and exclusion criteria  
Inclusion 
Criteria 
 Female aged 20 years old and above  
 Clinical diagnosis of rosacea  
 Lived with rosacea for more than 6 months 
Exclusion 
Criteria 
 Male 
 Females aged under 20 years old   
 Visible difference caused by other health conditions 
Diagnosis of body dysmorphic disorder 
 Lived with rosacea less than 6 months 
 Non English Speaking 
A total of six participants with a clinical diagnosis of rosacea were recruited. All 
participants were Caucasian ethnicity and the majority identified themselves as 
British (n=5), one described themselves as Polish. The average age of participants 
was 54 years and the average duration of living with rosacea was 11 years. 
Demographic information of participants is included in Table 2.2.  
 
 
 
73 
 
Table 2.2 Participant demographic information  
Participant 
Pseudonym 
Age Duration of 
Rosacea 
Rosacea Subtype 
Edith 49 10 years Unknown 
Hannah 69 10 years Unknown 
Grace 32 10 years Papulopustular  
Lucy 56 1 year Unknown 
Nicole 64 10 years Unknown 
Gemma 53 24 years Unknown 
 
Whilst there is no set sample size for IPA, the methodology focuses on a smaller 
data set to avoid losing the “subtle inflections of meaning” (Collins & Nicolson, 
2002, p.626; Smith et al., 2009). As such, the number of participants included in 
the research was considered to be suitable for IPA methodology.  
 
2.2.4 Analysis 
Each interview was transcribed verbatim and identifiable information was 
removed. Participant’s transcripts were analysed in line with IPA research 
guidelines (Smith et al., 2009) (see Appendix Q). Extracts of participant’s transcripts 
can be found in the appendices (see Appendix R).  In the initial stages of analysis, 
each transcript was explored separately. This involved a line by line analysis to 
identify emerging themes for each participant. The initial themes that emerged 
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from each participant’s transcripts were then clustered together in order to 
identify super-ordinate and sub-ordinate themes that summarised participants’ 
lived experiences (see Appendix S).  
 
2.2.4.1 Research credibility 
The credibility of the research was considered in line with Elliott, Fischer and 
Rennie’s (1999) quality assessment guidelines. These guidelines are considered to 
be an effective and pragmatic approach for evaluating qualitative research in 
health psychology (Smith, 2003). Each step of analysis from the transcripts through 
to final themes was discussed and reflected on with the supervisory team. A peer 
on the doctorate course initially coded an extract of a participant’s anonymised 
transcript for verification of the credibility of the analysis. The similarities and 
differences between the two perspectives were explored and reflected upon 
(Yardley, 2000).  
 
2.2.4.2 Researchers position 
Credibility of the research was also considered within a reflexive account of the 
researcher’s position towards the project. The researcher was a trainee clinical 
psychologist and was on placement in the service where participants were 
recruited from. The researcher felt this was helpful to develop an awareness of the 
project within the NHS department as well as increasing the rapport with the 
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dermatologists involved in screening possible participants against the inclusion 
criteria.  
 
The role of the researcher is a key consideration within IPA methodology as they 
influence the dynamic process of understanding and making sense of participant’s 
personal worlds (Pietkiewicz & Smith, 2014). Prior to the interviews, the bracketing 
process highlighted the researcher’s assumption that rosacea would be a negative 
experience for participants.  This assumption was likely to have been developed 
from a review of the literature on the psychosocial factors associated with rosacea, 
as well as the researcher’s own personal experiences of living with a visible 
difference. Without an awareness of this assumption, it could have influenced the 
researcher’s ability to be open to participant’s experiences, particularly towards 
exploring their strengths or positive experiences of living with a visible difference. 
A reflective diary was used throughout the research and reflections on the 
interview process was discussed with the supervisory team.  
  
2.3 Results   
Two superordinate and seven subordinate themes emerged from the analysis of 
the data. As shown in Table 2.3, the superordinate themes consist of; 
‘Concealment’ and ‘It’s a battle isn’t it’. Verbatim extracts of participant’s 
transcripts are used to highlight each theme as well as the convergence and 
divergence that occurred within participant experiences.  
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Table 2.3 Superordinate and subordinate themes  
Superordinate Themes Subordinate Themes 
Theme 1: Concealment  1a) The need to conceal   
1b) Being exposed  
1c) Putting on a brave face  
Theme 2: “It’s a battle, isn’t it”   
 
2a) “Keeping it at bay”   
2b) Costs of the battle  
2c) Finding a cause   
2d) Personal Strength   
 
 
2.3.1 Theme 1: Concealment   
All participants described concealing their experiences of rosacea from other 
people. Three subordinate themes emerged; the need to conceal, being exposed 
and putting on a brave face. Within each of these subordinate themes, 
concealment seemed to be dependent on the perception of rosacea and the 
social environment.   
 
2.3.1.1 Theme 1a: The need to conceal  
All participants described concealing rosacea by wearing make-up or avoiding 
triggers that increased the visibility of their skin condition. Three participants 
reflected how their use of cosmetics enabled them to conform to the social 
construction of beauty and femininity.  
77 
 
  
“I mean regardless of the rosacea anyway, I would wear make-up because 
that’s what women do”  
(Grace, line 401-402) 
 
Grace described how her rosacea “adds another level” to her make-up use, 
expressing the need to conceal her skin condition in order to “fit in with 
everybody else”. The frustration this caused was emphasised through her tone of 
voice.  
 
“you’ve got people that have got really, really bad skin conditions and 
they’re battling away, behind-the-scenes going oh, you know, I’ve gotta 
plaster myself with make up today just to look normal” 
(Grace, line 179-181)  
 
For Lucy, rosacea acted as a misrepresentation of her identity, causing her to feel 
“embarrassment” and “shame”. The incongruence between her internal self and 
the external representation of her identity was emphasised by describing her 
body as a “shell”.     
 
“It’s like people have got this perception that they’ll meet you and within 
three seconds they’ll decide what you, who you are like, or what you are 
and it actually isn’t and it’s just a shell” 
       (Lucy, line 260-262) 
78 
 
 
This seemed to force Lucy to use make-up to hide her rosacea from other people 
in order to conform to the social expectation of concealing visible differences.  
 
“I think, that [make-up] will feel like a chore because it doesn’t come 
natural to do it, erm, and, that I’ll forget I’ve got it on and wipe something 
and I’ll realise I’ve got a white top on, and, you know, because I’ve-I’ve not 
been that way inclined in the past, erm, but I think to a degree, people 
expect you to hide it. (Pause). There’s an expectation from other people 
to keep it covered and for you to look your best, every day as you go to 
work or whatever and, erm, I can see me falling into that”   
(Lucy, line 331-335)   
Lucy’s reflections seemed to resonate within Edith’s experiences as she reflected 
on how she did not like make-up, but felt she had to use it “every morning, every 
evening”. For Edith, she described the need to conceal her skin condition as it 
made her feel “like a second class of people”. During times when she was unable 
to hide her rosacea, she described being rejected by other people based on her 
physical appearance.   
 
“But anyway, it would be nice to look normal so people don’t erm. I 
remember as I said how people look at me, with err, erm, how to say, that 
I look disgusting, for-for myself as well anyway”  
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(Edith, line 149-151)  
 
In contrast, Hannah described “everybody” to perceive her rosacea to be “just 
one of those things”. At times, Hannah shared this co-construction of rosacea, 
stating “it was fine, I coped it wasn’t a really major problem”. However, at other 
times, she expressed an annoyance towards the minimisation of her skin 
condition “coz you think well it’s not one of those things to me”. Her reflections 
imply that, at times, Hannah experienced a struggle between the personal 
experience of rosacea and her friends and family’s understanding of her skin 
condition. This, along with the impact it had on her confidence, may be why she 
felt the need to physically conceal her symptoms.  
 
“Sometimes my husband says to me you know, “I don’t know why you’re 
worrying because it’s not that bad”, and (whispers) oh I know, but I just 
want to make sure this wasn’t showing. You know, if I-I have been on-on 
occasions gone out with him and if I feel like we’ve gone somewhere and 
we’ve gone – I’ve gone all hot, and I’m thinking, saying do you know 
(whispers) are my spots showing? [husband] No (elongated 
pronunciation).” 
 (Hannah, line 427-431) 
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2.3.1.2 Theme 1b: Being Exposed 
All participants except Hannah made reference to rosacea placing them within a 
disempowered position, regarding which aspects of their identity they could keep 
private and what was made public for other people to see and critique.  Lucy 
likened this as “opening up your soul” to other people, increasing a sense of 
vulnerability and “exposing too much” of her sense of self. Lucy described how 
her feelings of exposure were exacerbated when a photograph was taken of her 
face without make-up.  Her use of the words, “whole naked body” implies 
without make-up, she felt stripped back, defenceless and unable to protect 
herself from the judgement of other people.  
 
 “It’s exposing yourself, even though it’s on the skin, that’s exposing me, 
my vulnerability and I felt vulnerable and that’s really weird, all I’m doing 
is showing the skin on my face but I feel like I, I might as well have 
exposed my whole naked body to you” 
 (Lucy, line 574-577) 
 
For Nicole, she described how other people mistook her rosacea symptoms to 
represent feelings of embarrassment. Her elongated pronunciation and observed 
changes in the intonation of her voice emphasised how this exposed her to 
judgement and mockery of other people and in turn, led her to feel 
embarrassment and frustration.  
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“When I worked it was a lot more embarrassing when I worked, erm, you 
know, just people seeing you and saying look at it (high pitch). Why you 
red like that. Aww (elongated pronunciation), Nicole’s really embarrassed 
of, you know, something was said, and I only laughed, do you know what I 
mean, I wasn’t particularly embarrassed but they’d automatically take it 
that I was embarrassed because I’d colour up that much”.  
(Nicole, line 83-87) 
 
Edith described how her skin condition not only exposed her own feelings of 
“disgust” towards her rosacea, but also revealed her social positioning to be on 
the “lower shelf” in comparison to “normal” people. This seemed particularly 
poignant when she described her daughter’s “honest” comments about rosacea, 
reflecting the loss and sadness she experienced due to feeling rejected as a 
mother based on her physical appearance.  
 
 “It hurt me. Err, sometimes it erm, make me feeling that she would prefer 
another mother, nicer younger. I don’t, I don’t know why. Sometimes her 
behaviour or sometimes she doesn’t like kiss, I don’t know, because of this 
(points to face). Erm. Err, I notice in other kids they love their mother 
however they look, but she sometimes say oh she look nicer than you.”  
(Edith, line 606- 609) 
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Grace described when her rosacea symptoms increased in severity, her facial 
appearance became “the pinnacle of awful” and she was unable to conceal her 
rosacea with make-up. During this time, she reflected on the responses towards 
her rosacea from members of the public. The religious connotations highlighted 
by the word “hell” and use of a simile emphasised the shock of “the people” 
towards her appearance as well as exposing her struggle to perceive her face to 
be “normal”. 
 
“I think I looked like I got leprosy or something, like, it-it would just be, the 
people would just judge you on your face, basically, just look- take one 
look and go what the hell is the matter with that girl-” 
(Grace, line 195-197) 
 
Gemma described how other people mistook her symptoms to signal “stress” and 
being “embarrassed”. Her reflections implied at her workplace, these emotive 
states were associated with an exposure of incompetence and weakness, causing 
her to use “war paint” to “stand out” against other people’s interpretations of 
her emotional state.  
 
“I was trying to pass a catheter and one of the staff nurses said to me, you 
don’t, you shouldn’t be embarrassed at looking at bodies, you know, 
you’ve chosen this profession and it was, you know, quite, I found that 
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quite hard coz, you know, I’d had four babies, I know, I know what bits 
and pieces look like”  
(Gemma, line 47-50) 
 
As well as the exposure of negative responses, Grace and Lucy also described 
how rosacea exposed other people’s compassion and sympathy. This was 
revealed by offering treatment suggestions and wanting to learn more about the 
lived experience of rosacea.  
 
“My friends mum’s got it and so were having the discussion going oh my 
mums tried this cream why don’t you try this or oh she got this from this 
pharmacy online and it worked for her, erm, so, so yeah that-that was 
recently actually we were discussing that with one of my close friends, so, 
erm and their like oh someone else has got it and, so it’s nice to know that 
with even your own circle of friends people are aware of what it is” 
 (Grace, line 792-796) 
 
2.3.1.3 Theme 1c: Putting on a brave face 
The accounts of five participants reflected the importance of masking their 
difficulties from other people.  In her struggle to keep her difficulties with rosacea 
“private”, Lucy described wearing an “emotional mask” for individuals she 
considered to be “on the periphery” of her life.  
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“I’d like an easy life but life is never easy but I don’t want stuff to beat me 
the vast majority of times so I put this mask on then, I’ll probably crumble 
somewhere else, erm, but I’ve forced myself to do it. And I-I don’t like 
other people to know unless they’re really close to me. - But apart from 
that it’s, oh yeah everything’s fine, that was my word, yeah fine, and 
that’s one of my mask words, fine.” 
 (Lucy, line 361-366)  
 
For Grace, Edith and Hannah, they minimised the impact of their rosacea by 
comparing the condition with other physical health problems.  
 
“Rosacea’s annoying, but it’s not life-threatening and it’s not, erm, you 
know, it’s one of those things, that you get on with but it’s not, err, a 
massive medical problem that’s going to kill you is it”.  
(Grace, line 693-695) 
 
Whilst this provided participants with a wider context to their conceptualisation 
of rosacea, for Hannah, her reflections indicated that this minimisation restricted 
her capacity to acknowledge the challenges her skin condition had caused her.  
 
“Why was I the one that sort of this-this happened to. But. But as I say, its-
it’s not you know, I’d have something to complain about if it was a, you 
know, a real disability that I’d got, then, so, it-it’s nothing compared to 
that”              (Hannah, line 102-104)  
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For Edith and Nicole, they described using humour in social situations with other 
people. Nicole’s intake of breath is suggestive of masking her feelings related to 
the unpredictability of being “red”.  
 
“I-I know I’m red and I say am I red, she’ll [sister] say a bit. And I get my 
mirror out and have a look and I’ll say, (big in-take of breath) I look at my 
mirror and look at her face and say I’m as red as your lipstick (laughs)” 
        (Nicole, line 108-110) 
 
However, Edith’s account also highlighted the emotional toll of masking her 
difficulties through the use of humour. This was highlighted when she described a 
time when she “tried to be fun” with her daughter. 
 
“For example, I tried to be, err, I am full of energy, and I tried to smile and 
after like this I feel like an old woman. And my own daughter doesn’t like 
me. (Tearful, long pause). As I said the most you cry if you are unhappy 
with your life” 
       (Edith, line 623-625) 
 
2.3.2 Theme 2: “It’s a battle, isn’t it”  
All participants described rosacea to be a condition that required the continuous 
use of treatments and skincare products. Participants discussed the limited 
effectiveness of their treatments and the variety of methods they have used to 
manage rosacea. Within their treatment journey, the struggle for power and 
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control over their rosacea was evident across four subordinate themes; “keeping 
it at bay”, costs of the battle, finding a cause and personal strength.  
  
 
2.3.2.1 Theme 2a: “Keeping it at bay” 
Participants often externalised rosacea, referring to their skin condition as “it”. 
Grace described living with rosacea to be a “battle”, trying a variety of methods 
to “keep it at bay”. For Gemma, the unpredictable nature of her rosacea “flare-
ups” emphasised her struggle in keeping her symptoms at bay.  
“You can’t predict how it’s gonna be, I mean it could be, I could walk in 
here, one day and my skin would all just flush and it could be something 
as simple as like if there’s a plug-in on the wall or you know, those sort of 
things tend to irritate it as well kind of almost like a chemical attack, if you 
know what I mean, so you just don’t know what you’re walking into and 
what could trigger it”  
(Gemma, line 190-193) 
Edith also described the management of her skin condition to be a continuous 
“fight”, feeling more empowered and in control when her symptoms had 
improved and she had lost weight.    
 
“I was like I can do everything. And I remember I still, I had-I had a lot of 
power because I was lighter, I felt very, very attractive” 
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 (Edith, line 389-390) 
However, on days when her skin condition had increased in severity, her account 
reflected feeling defeated and powerless, impacting several aspects of her life.    
 
“When I was with these problems, you could see my eyes like dead. Just, 
(sighs) sometimes still I feel like this err, that if I am-if I am in bad mood 
and bad condition and everything and my daughter and face and 
everything. Just I, if I walk you can see in my eyes no-no life.”  
(Edith, line 413-415)  
 
Edith’s reflections were reiterated in Lucy’s account as she described feeling “on 
a high” when her treatment was keeping “on top of it”. However, prior to seeing 
a consultant, she also described how her symptoms felt unmanageable, causing 
“a negative thought spiral” and invoking feelings of hopelessness.  
 
“-you look in the mirror you don’t think your good, good enough for 
people to look at and it just then starts tipping you down, even lower, 
erm, and it’s like, erm, like a hole with a ladder in and you’re on the edge 
of the hole when you’re not feeling good and then you look in the mirror 
and think oh god there’s another one there and another one there, so you 
down a rung and then somebody will have looked at you at work quite 
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deeply, and it’s obvious they are looking at your face so you go down 
another rung on the ladder”  
(Lucy, line 621-627)  
 
Three participants described how their experiences with General Practitioners 
(GP) had made it difficult to keep rosacea at bay. For Gemma, she described how 
her GP considered rosacea to be unimportant, perceiving them to provide her 
with a prescription whilst thinking “that’ll probably fix it, go away”. This was 
reiterated by Grace who described a time when her rosacea symptoms “flared 
up” due to her GP refusing to provide her with any medication to “get it under 
control”.   
“I had to go cold turkey with absolutely no alternative that they could 
offer me. Erm, and my face just, absolutely I think it was the hormones or 
something but the worst it’s ever been, absolutely flared up ridiculously, 
erm, to the- and then I went back to the GP and they washed their hands 
saying look it’s so bad we don’t want to prescribe anything without you 
seeing a dermatologist because, erm, we don’t want to make it worse” 
       (Grace, line 47-51) 
 
In contrast, Hannah described how her GP encouraged her to try multiple 
treatment options to manage her rosacea. The repetition of “let’s try” implied 
treating rosacea was a choice for Hannah, rather than a necessary process. 
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“I’ve taken lots of different types of medication, different types of creams, 
because the doctor kept saying well let’s try this one, let’s try this one-“ 
(Hannah, line 10-12)  
However, Hannah’s reflections also implied an internal battle between feelings of 
guilt for accessing NHS services “just because I’ve got a few spots” and being 
“relieved that at least something could possibly be done about it”. This suggests 
she may have found it difficult to express the importance she placed on treating 
her rosacea.   
 
2.3.2.2 Theme 2b: Costs of the battle 
The accounts of five participants expressed feeling frustrated about the financial 
cost of trying a variety of medical treatments and cosmetic products.  
 
 “The creams on the market are very expensive and generally don’t work 
(laughs). For, erm, very well anyway and I just like, it’s an expens-err, an 
expensive waste of time, basically. Until you do find one that perhaps 
works for you, but then I’ve had to spend hundreds of pounds to get to 
that point” 
(Grace, line 462-465) 
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Although Gemma described finding an effective make-up product “changed my 
life”, Gemma and Lucy also expressed feeling guilty about the amount of money 
they had spent on their physical appearance.  
 
Social difficulties arising from the management of rosacea was expressed by 
Edith. She described a conflict between her desire to protect her daughter from 
the harmful effects of her medication and feeling like a “cold mother”. Edith’s 
tearful presentation and softer tone of voice emphasised the sadness at the loss 
of intimacy with her daughter.  
“Yeah she, I tried to you know be close to her but err, sometimes I notice 
last time, don’t touch me because I have medicine. (Whispers) Don’t 
touch me.”  
(Edith, line 352-353) 
 
The relational consequences of treatment was reiterated by Gemma, who 
described experiencing difficulties within her relationship due to her night time 
skin regime.  
 
“He was saying to me, oh my God, you know, you’ve always got stuff all 
over your face, you don’t need that, you know, you don’t need to go to 
bed covered in loads of cream, so he wasn’t, his lack of empathy and 
understanding didn’t help with our relationship” 
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(Gemma, line 142-145) 
 
In addition to the social factors, four participants reflected concerns about the 
side effects associated with their medical treatments. Whilst Grace and Nicole 
both reflected feeling concerned they could become anti-biotic “resistant”, Nicole 
also described the physical health risks associated with her search for an effective 
treatment method.  
“there’s things saying, that it could, you know, you have to really watch 
the sun, it could cause, they can cause skin cancer and, different things 
and I do go away on holiday quite a lot so and that concerned me and I 
didn’t find they worked” 
(Nicole, line 287-290) 
2.3.2.3 Theme 2c: Finding a cause 
The uncertainty towards the cause of rosacea was reflected within all participants 
lived experiences. “Parasites”, difficulties with the “immune system”, 
“hormones”, “pregnancy”, “genetics”, “old age” and “god” were all indicated as 
factors associated with the onset of the condition. For Hannah, she described 
always looking after her skin which made it difficult to understand the 
development of rosacea, creating a sense of unfairness and frustration.  
 
“So, I just think sometimes well err, I’ve-I’ve-I’ve always, as far as I’m 
concerned, you know did everything that I had to-to keep my skin clean 
and, you know erm. Make-up remover and everything else and you think 
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well, why is it- you know, you just can’t understand if you do everything 
you feel is necessary to have your skin without spots, you know. Why 
does-why does it happen?”  
(Hannah, line 148-152) 
 
Whilst Edith described feeling “scared” following her diagnosis of rosacea, Grace 
described her diagnosis experience to be “positive”, providing her with an 
“official label” that helped her to make sense of her skin condition. However, 
Grace’s experiences also expressed an internal struggle to sit with the uncertainty 
that surrounded the cause of her skin condition.   
 
“I like to have a reason for things and if you-you haven’t got a reason for it 
you just kind, of always thinking in your head (pause) why? Or why is it? 
Or could it be this, or could it be that or if I try this, if I cut out this in my 
diet, would that help? You always want to try and strive to-to get a 
reason. And it’s hard when there isn’t one” 
    (Grace, line 245-248) 
 
The difficulty in not being able to find out the aetiology of her rosacea, seemed to 
be associated with Grace’s motivation to seek more information and try different 
strategies to alleviate her symptoms. Prior to Lucy’s diagnosis, she described 
feeling she was “to “blame” for the onset of her rosacea, causing her to feel 
embarrassed and avoid social situations.  
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“I just felt too embarrassed about the way I looked, erm, and to a degree, 
I think I felt ash-ashamed of the way I looked because I felt in a way until I 
knew it was rosacea that I blame myself, it’s something I’ve done.” 
 (Lucy, line 213-216) 
 
When Lucy described her experience of being diagnosed with rosacea, she 
reflected how it had provided her with a sense of empowerment and relief, 
despite the restrictions in the length of the appointment.  
 
“And in that seven minutes, I learnt more and felt a lot better than I had 
done in two or three years”  
(Lucy, line 75-76) 
 
2.3.2.4 Theme 2d: Personal strength   
The need to have personal strength and resilience to live with rosacea was 
reflected in five participants’ experiences.  For Grace, she described herself to be 
a “resilient person” and by having a “thick skin” she was able to “just get on with 
life” despite receiving judgemental comments from other people.  
 
 “So, I was just like, forget this, I don’t care anymore, I’m just gonna take 
to, wear it, to give my skin a break and just go out without make-up and, 
erm, and just get on with it, so. Whereas, I think probably other people 
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would probably lock themselves away, the way I looked, (laughs). And just 
go I never wanna go out again err, because it was so, it was very, very 
bad.” 
(Grace, line 253-256) 
 
The need for personal strength to live with rosacea echoed within Gemma’s 
experiences. By comparing herself to other people, Gemma emphasised the 
strength of her personal attributes and how it has helped her to live with her skin 
condition.  
“I’m quite a stoic person but I can see why somebody would get 
desperate”  
(Gemma, line 395-396)  
 
For Hannah, she described herself as an “out-going” person whereby “nothing 
sort of holds me back”. Throughout her experiences, Hannah reiterated how she 
“coped” with rosacea.  This implied the strength of her character was an 
important component of her experiences and towards her construct of rosacea.  
 
“ It’s just how I am personality wise I just, you know, just get on with 
things and cope as best as I can”  
(Hannah, line 46-47) 
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In contrast to the experiences of other participants, Lucy described her personal 
strength to develop following the onset of her skin condition, through a process 
of “learning to manage” her symptoms. The development of her resilience and 
empowerment was reiterated through her tone of voice and use of short 
sentences. 
 
“There’s only you that can climb yourself back up with the assistance from 
other people, so and like, being able to say, yeah that’s ok. I’ve got rosacea. 
This is it. This is me. Erm. I’m dealing with it”  
(Lucy, line 627-629) 
 
2.4 Discussion  
The research aimed to provide an exploratory account of the lived experiences of 
women who had a diagnosis of rosacea. Two superordinate themes emerged from 
the data and will be considered in relation to existing literature. Research 
limitations, as well as implications for further research and clinical practice will also 
be discussed.   
 
2.4.1 Discussion of the findings  
2.4.1.1 Theme 1: Concealment    
Participants’ lived experience of rosacea reflected feelings of low mood, anxiety, 
shame and difficulties with confidence. Participants’ accounts were consistent 
with findings from quantitative research which has found participants with 
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rosacea experienced anxiety and depression (Egeberg et al, 2016; Moustafa et al 
2014; Su & Drummond, 2012). However, participants’ also described the 
importance of minimising their emotional difficulties and concealing them from 
other people. Whilst it is recognised the findings of the current research are 
based on a small sample size, it is possible other people with rosacea may also 
minimise the difficulties they experience. Furthermore, if participants’ minimised 
their difficulties on the self-report measures used within quantitative research, it 
could indicate the psychosocial factors associated with rosacea are under-
reported within the literature.  
 
Physical appearance played a key role in the external representation of 
participant’s identity. Participant’s described the need to conceal their skin 
condition through the use of make-up in order to prevent rosacea becoming part 
of their self-image. It is possible, their use of concealment and minimisation of 
their experience of rosacea reflected a coping process that enabled participants 
to adjust to living with a visible difference. The association between physical 
appearance and identity has also been reflected within the experiences of people 
living with other visible differences (Thompson & Broom, 2009). Furthermore, the 
need to conceal differences in appearance is consistent to research that has 
explored the lived experience of people with vitiligo (Thompson, Kent & Smith, 
2002). However, in contrast to the current study, the social support provided to 
people with vitiligo was a central theme to their experiences and for some 
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participants, it supported the acceptance of their skin condition (Thompson et al., 
2002). 
 
The majority of participants’ in the current study expressed feelings of 
embarrassment within social situations and reflected on the challenges to “fit in” 
with society and conform to social norms. The emotional difficulties described by 
participants’ seemed to be more pronounced during times of increased symptom 
severity. These reflections are consistent with quantitative research that found a 
negative association between symptom severity and perceived quality of life (Van 
der Linden et al., 2015). However, the accounts of participant’s’ experiences 
enrich the current understanding as they also described feelings of powerlessness 
and exposure to social judgement when their rosacea symptoms increase.  
 
The nature of participants’ social interactions contributed to the way they 
conceptualised their skin condition. The majority of participants’ described 
receiving judgemental comments and being “stared at” by other people which led 
to feelings of rejection, embarrassment and low mood. These findings are 
consistent with other research which found that feelings of stigmatisation 
increased the likelihood of developing anxiety and depression in people living 
with rosacea (Bohm et al., 2014). However, Grace and Lucy also described other 
people to show sympathy and compassion for their skin condition, offering 
support and advice on treatment. This suggests both positive and stigmatising 
social factors are important to consider in understanding the lived experience of 
rosacea.  
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2.4.1.2 Theme 2: “It’s a battle, isn’t it” 
Research into the factors associated with rosacea have predominantly focused on 
understanding the effectiveness of medical treatments, (Powell, 2005; Van 
Zuuren et al., 2015) rather than exploring the experiences of those treatment 
methods.  Whilst findings from qualitative research suggest people with rosacea 
primarily use online forums to discuss treatment options (Alinia et al, 2016), the 
current findings extend the understanding within the literature, as participant’s 
described their struggle to keep rosacea symptoms at bay in context of the 
limited effectiveness of medical treatments. Furthermore, participant’s 
reflections enrich the understanding of the treatment process as the range of skin 
care products and medical treatments participants tried seemed to be driven by 
feelings of powerlessness, embarrassment and hope for a ‘cure’.  
 
Through the use of IPA methodology, participants were able to express their 
experiences of healthcare services. Divergence was found in their experiences of 
being diagnosed with rosacea. For some participants, being diagnosed with a 
“label” provided them with relief, hope and validation. However, other 
participants described their diagnosis as unhelpful. It is possible the differences in 
the diagnosis experience reflects the individual differences and needs of 
participants. However, it could also suggest the way in which a diagnosis is 
provided is key to the conceptualisation of rosacea, service user satisfaction and 
towards the management of the skin condition (Halioua, Fournier, Bourcier & 
Alvarez, 2014). Divergence was also found in how participants experienced the 
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support offered by their GP’s. It is possible these differences could reflect the 
current inconsistencies in funding, resources and specialist training for skin 
conditions across primary care services (APPGS, 2013; Krasuska, Millings, Lavda & 
Thompson, 2016).  
 
Personal strength and resilience featured in participant’s accounts of the 
management of rosacea. Whilst this has not been reported in studies that have 
explored the psychosocial factors associated with rosacea, personal growth, use 
of humour and inner strength have been found in the adjustment of other visible 
differences (Egan, Harcourt & Rumsey, 2011).  It has been argued that resilience 
and personal strength are important factors to consider as they provide a more 
balanced and enriched perspective into the lived experiences of visible difference 
(Rumsey & Harcourt, 2004). Furthermore, a systematic review found resilience to 
be positively associated with perceived quality of life and management of 
physical health conditions (Cal, Ribeiro De Sa, Glustak & Santiago, 2015). As such, 
this suggests, an individual’s resilience is an important factor to consider and 
monitor in the provision of medical treatment.  
 
2.4.2 Methodological Limitations 
The findings of the current study should be considered in light of several 
methodological limitations. All participants were from a Caucasian ethnicity 
which limited the understanding of the lived experience of rosacea from other 
ethnicities and cultural backgrounds. Whilst the sample size was consistent with 
the chosen methodology, the majority of the research exploring rosacea 
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employed quantitative methods and as such, the results of the current findings 
are difficult to compare to the current literature.  
 
The parameters of the inclusion criteria meant that the duration of rosacea varied 
from one-twenty four years which created a richness to the data in the length of 
time participants lived with the condition. More specifically, it provided the 
opportunity for some participants to reflect on their conceptualisation of rosacea 
and use of different treatment methods across a number of years. However, the 
variation in the duration of rosacea may also have caused a difference in the lived 
experience of the condition.  
 
Triangulation of data can be achieved through a variety of methods, all of which 
aim to increase the credibility of research findings (Tonkin-Crine et al., 2016). 
Although triangulation of data was considered within the current research, due to 
time constraints and difficulties experienced in the recruitment process, it was 
not possible to offer participants the opportunity to be included within the 
triangulation process.   
 
 
2.4.3 Research Implications 
To address the gaps within the literature, the exploration of the lived experience 
of men with rosacea, as well as people from a range of different ethnic and 
cultural backgrounds should be considered. Future research into the diagnosis 
experience provided by GPs and by dermatologists would be helpful in gaining an 
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understanding of the lived experience of rosacea across different services. 
Furthermore, based on the limitations of the current research, future studies 
should consider the duration of rosacea as an inclusion criteria.  
 
 
2.4.4 Clinical Implications 
Participant experiences highlight the importance for clinicians to be mindful of 
the psychosocial factors that can occur for people living with rosacea. This could 
be supported by the use of mental health and quality of life outcome measures in 
order to detect any changes in client’s emotional wellbeing during the treatment 
of rosacea. Alternatively, clinicians could ask clients to provide a subjective unit of 
distress score (SUD) at each appointment which can be helpful in monitoring 
treatment outcomes (Kaplan & Smith, 1995). Furthermore, due to participant’s 
minimisation of their difficulties in living with rosacea, GP’s may benefit from 
training and consultation to support the exploration of psychosocial factors, 
screening for and supporting people with psychological distress and signposting 
to appropriate services.   
 
The reflections within the subordinate themes of ‘the need to conceal’ and ‘being 
exposed’ indicate medical professionals could provide service users with the 
option of being referred to make-up camouflage services. These services aim to 
help individuals “gain self-confidence and independence” in living with visible 
differences (Changing Faces, 2017). However, consistent with other skin 
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conditions, referral to camouflage services need to be carefully considered and 
need to be broached with clients in a sensitive, compassionate manner.   
 
Participants’ motivation to try a variety of treatments indicates the treatment 
process can be therapeutic, providing a sense of empowerment to service users. 
However, participants’ lived experiences also highlight the need for clinicians to 
carefully consider the ethical implications associated with continuously providing 
a variety of treatment options that are ineffective for service users. Whilst a 
conversation about the prognosis of rosacea and the limited effectiveness of 
treatment may be challenging, clinicians may find it helpful to reflect on this with 
service users at diagnosis and/or early on in the treatment process. Furthermore, 
additional supervision and communication skills training could be beneficial for 
clinicians.  
 
As the leading organisations for supporting rosacea are predominantly based 
within America, (National Rosacea Society, 2017) the development of a UK based 
support group for people with rosacea could help individuals to feel supported, 
increase social networks and share knowledge of helpful ways to manage 
rosacea.  
 
2.5 Conclusion 
The current study provided an exploration of the lived experiences of women 
with rosacea. The idiographic and phenomenological approach enriched the 
current understanding of the conceptualisation of rosacea, diagnosis and 
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treatment experience. The clinical and research implications indicate medical 
practitioners need to consider the psychosocial factors associated with living with 
rosacea in order to address any unmet needs.  
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3.0 Introduction  
Reflexivity is a key part of the research process, starting from the formulation of a 
research question to the conclusion of a project (Berger, 2015). However, 
reflexivity within qualitative research is complex and requires the researcher to 
reflect on their own beliefs and assumptions as well as the interpretation of 
participant’s lived experiences (Mayhut & Morehouse, 1994). As researchers are 
recommended to “see themselves in fundamentally the same way as they see the 
people they are studying”, (Proctor, 2009, p. 93) the use of a psychological model 
can be an effective method to support reflexivity within a research project. 
Acceptance and Commitment Therapy (ACT) is a trans-diagnostic model that is 
widely used within psychological services and is considered to be an effective 
method for supporting a range of mental health difficulties and physical health 
conditions (A-Tjak et al., 2015; Dahl, 2009).  In addition to its use with clients, the 
ACT model also provides a useful framework for clinicians to consider their own 
values and difficulties (Harris, 2009; Levin & Hayes, 2009).  
 
 The aim of this paper is to provide a reflective account of the research 
experiences captured within the reflective journal I completed throughout the 
research process. To support psychological flexibility, my reflections are 
structured within the six key dimensions of the ACT Hexaflex model; values, 
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cognitive defusion, acceptance, contact with the present moment, self as context 
and committed action (Harris, 2009).  
 
3.1 Moving towards my values  
Individual core values are considered to be life’s compass, providing a sense of 
meaning, purpose and motivation (Harris, 2009). Based on an individual’s values, 
their behaviour can be understood as either a helpful process that enables them 
to ‘move towards’ their values or signal a ‘movement away’ from achieving their 
desired goals (Harris, 2009). Prior to deciding on my research question, I recall 
feeling overwhelmed by the number of possible areas I could complete my 
research within. This was exacerbated by having discussions with clinicians and 
an exploration of the literature in several topic areas. At the time, my decision to 
complete my research within dermatology seemed to have occurred through a 
process of chance and opportunity.  
 
Considering my core values, I began to reflect on my professional practices and 
the importance I place on appreciating diversity and understanding other 
people’s experiences. I also became aware of the value I place on inclusion and 
acceptance. These values seemed to be rooted within my own previous 
experiences of living with a visible difference as well as my employment within 
several learning disability teams. In context of my values, the decision to work 
with a population group that are under-represented within the literature and 
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whose psychological needs have historically been overlooked and minimalised, 
no longer appears to have happened by chance. Instead, it is more conceivable 
that my values have not only shaped the development of my research question, 
but also, my identity as a scientific practitioner.  
 
In clinical practice, I truly value the opportunity to explore the subjective 
experience of service users, collaborating with clients to jointly make sense of 
their difficulties. As such, within the empirical paper, the ideologies underpinning 
Interpretative Phenomenological Analysis (IPA) seemed consistent with my own 
subjectivist epistemological position. During the research process, I felt 
passionate about my empirical paper and enjoyed adopting the hermeneutic 
approach of IPA. Following the completion of the database search within my 
systematic literature review, I observed a very different emotional response, 
feeling stuck in the process and at times, overwhelmed with the synthesis of the 
data. Reflecting on this, I wondered if the predominant focus of quantitative 
methodologies had initially seemed a ‘movement away’ from my values and 
epistemological assumptions. 
 
 I observed my perspective to shift when I was on placement within a physical 
health service as I experienced the importance of quantitative literature reviews 
within medical settings. More specifically, I became aware of the research-
practice link and how the generalisability of quantitative findings can help shape 
the commissioning bids for services, aid best practice and service development. 
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Reflecting on the completion of my systematic review, I feel more passionate 
about the findings. I am more attuned to how the review can be utilised within 
clinical practice and how the findings can support the needs of young people 
living with alopecia.  
3.2 Cognitive defusion versus cognitive fusion  
Within the ACT model, being reflective is central to the ability to separate 
ourselves from our thought processes (Hayes, Luoma, Bond, Masuda & Lillis, 
2006). Without reflexivity, we can become wedded to specific ways of thinking 
and perceive our thoughts and feelings to represent ‘truths’ that guide our 
patterns of behaviour (Harris, 2009). Halfway through my interview with one of 
the participants, Edith, I became aware of my preoccupation with my choice of 
language, increasing my use of ‘erms’, and pausing half way through my 
sentences in order to decide how best to express myself.  
 
Following the interview, I was concerned this had limited my ability to provide 
her with warmth and compassion, especially during times when she described 
experiences that were emotive for her. Initially, I found it difficult to reflect on my 
experiences, perceiving my thoughts to be ‘truths’ and I began to question my 
skills as a scientist practitioner. However, when transcribing the interview, I 
became curious about Edith’s description of feeling like a “cold mother” and 
wondered whether my emotional response reflected the counter-transference 
within the researcher-participant relationship. Reflecting on this process offered 
me an alternative perspective on my abilities and skills, and I was able to 
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reconsider my approach towards Edith. Before the completion of my empirical 
paper, I had not fully appreciated the personal challenges that can arise within 
qualitative methodology. Based on my experiences, I am more mindful of the 
processes that can trigger the vulnerabilities of the researcher, as well as the 
need to employ reflexivity throughout the research process (Dwyer & Buckle, 
2009).  
 
The language that is chosen to construct our reality is an important consideration 
of the ACT model, and is seen to bridge the gap between the internal experience 
and the social world (Harris, 2009). Within the interviews, participants described 
their experience of living with rosacea to be a “battle”, and a “fight”, requiring 
the use of “tools” and “war paint”. This construction of rosacea was seemingly 
emphasised by clinicians through the provision of different medical interventions 
and numerous GP appointments in order to manage the skin condition.  Prior to 
my research journey, I had considered the use of metaphors to be a helpful 
process in my psychological work with clients. However, it is suggested the use of 
metaphors and similes can be an unhelpful process, as they can restrict the 
construction of reality by emphasising a particular way of thinking (Lakoff & 
Johnson, 2003). Due to this, I wondered about the ramifications of using military 
terminology to describe the lived experience of rosacea and whether participant’s 
would feel they had ‘lost the battle’ or been ‘defeated’ if the severity of their 
symptoms progressed. Whilst my reflections on the language use of participant’s 
with rosacea are somewhat tentative, they are consistent with research findings 
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that have explored the use of military language within cancer services 
(Czechmeister, 1994; Semino et al., 2017). By reflecting on the use of language, I 
feel it has provided me with a more balanced perspective towards the use of 
metaphors within my clinical and research practice. As such, I feel more equipped 
to recognise when they can be beneficial to a client’s conceptualisation of their 
experiences and when they can create additional challenges for service users.  
 
The positive functions of humour are often debated amongst healthcare 
professionals and largely depend on the clinician’s viewpoint (Martin, 1996). 
Within the interviews with Nicole and Edith, I perceived their use of humour to be 
self-deprecating, invoking my feelings of compassion and sympathy towards their 
experiences.  Following their interviews, my original assumptions, recorded 
within my reflective journal, indicated my potential of becoming fused to the idea 
their humour was disempowering. As such, I was at risk of avoiding other 
interpretations of their language use. However, by bracketing my original 
assumptions, my perspective shifted within the coding process. As such, I was 
able to acknowledge how their use of humour had enriched the descriptions of 
their experiences. This process has affirmed the importance of not relying upon 
my assumptions to understand the construction of other people’s experiences 
but rather, to try and understand the meaning behind the use of language and 
the variety of functions humour can serve (McCreaddie & Wiggins, 2007). 
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3.3 Acceptance   
Acceptance is an active and dynamic process where challenging events, thoughts 
and feelings are embraced without needing to change or avoid them (Hayes et 
al., 1999; Hayes et al., 2006). During the research process, I was afforded the 
opportunity to shadow a dermatology hair loss clinic. Within this clinic, I was 
particularly struck by the emotive content of clients’ experiences and in their 
descriptions of being “ugly”, “weird” and “unfeminine”.  Following the clinic, I 
began to reflect on my own construction of beauty and upon the social processes 
that create an ‘ideal’ beauty for women to strive towards (Gallagher & Pecot-
Hebert, 2007). I felt a sense of shame towards my reflections as I wondered if my 
own conformity played a part in maintaining the rigidity of the social norms of 
beauty that can cause difficulties for people living with visible differences. Whilst 
this awareness has been challenging to accept and conflicts with my desire to 
celebrate diversity, I am more aware of the tension between my own actions and 
the social processes that are driving them.  
 
3.4 Contact with the present moment 
Focusing on the ‘here and now’, rather than ruminating on past and future events 
is an important part of maintaining psychological flexibility (Harris, 2009). At 
different points during the research process, I found my thoughts began to 
ruminate on the time constraints associated with the completion of the thesis. 
This was especially evident during the process of gaining appropriate ethical 
approval. Whilst I firmly believe ethical codes of conduct are integral to clinical 
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and research practices, at times, I found the process challenging to navigate, 
particularly due to the introduction of gaining HRA approval amidst the 
submission of my ethics application. Furthermore, my anxieties towards the time 
frame of my research project was exacerbated by the restructuring of the local 
research and development team and the length of time they required to process 
my application.  
 
Overall, I experienced this process to be stressful, causing me to ruminate on 
possible future consequences and as such, it created a barrier in my ability to be 
within the present moment. It is likely the difficulties I experienced highlighted a 
conflict between my value to act ethically and my desire to fulfil the 
requirements of the doctorate programme and professional training. However, 
on reflection I feel the ethical approval procedure has increased the rigour of my 
project and improved the experiences of participants, as it has ensured ethical 
practices have been thoroughly considered throughout the research process.  
 
The use of bracketing in research can help mitigate the potential influence of 
unacknowledged research assumptions and allow the researcher to focus on the 
‘here and now’ of participant experiences (Tufford & Newman, 2010). The 
opportunity to explore my own thoughts and assumptions towards rosacea has 
been a valuable experience. Prior to conducting the interviews, I was able to 
acknowledge my beliefs towards visible difference and to understand my 
assumption that living with rosacea would be a negative experience.  I found 
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bracketing to be a beneficial process as it enabled me to focus on how 
participant’s described their lived experience, remain within the present moment 
and prevented the direction of the interview being channelled by my 
preconceived assumptions.  
 
3.5 The context of the self  
The importance of striking a balance between the ‘thinking self’ and the 
‘observing self’  is emphasised within the ACT model as it allows individuals to 
become aware of the distinction between “sensing and what is sensed” 
(Carrasquillo & Zettle, 2014, p. 660; Harris, 2009; Hayes et al., 1999).  Reflecting 
on participant’s difficulties in separating the private and social parts of the self 
particularly resonated with my experiences of training on the clinical psychology 
doctorate course. Whilst my experiences have enabled me to foster the 
development of my ‘observing self’, at times, my vulnerabilities have felt exposed 
and open to the judgement and critique of my peers, clinical tutors and 
supervisors. For trainees, discovering the limitations of beliefs and 
epistemological assumptions can be challenging (Davidson, Harper, Patel & 
Byrne, 2007). However, I have also found training to be a rewarding experience 
and I am more attuned to my identity within my professional practice and in 
acknowledging my strengths as a clinical and scientific practitioner.  
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Within qualitative research, the researcher is considered to adopt either an 
‘insider’ or ‘outsider’ position to the population they are studying (Hellawell, 
2006). At the start of my research journey I had assumed a prior knowledge to 
the topic area due to my previous experiences of living with a visible difference. 
As such, I considered myself to adopt an ‘insider’ position. However, during the 
coding process, I wondered whether participant’s had positioned me as an 
‘outsider’ which was reflected within some of their comments  “probably you 
can’t imagine because you are- you have normal skin” -“you see people- like 
yourself you’ve got nice clear skin”- “do you know what I mean”. The differences 
between my original assumption and participant’s experiences of me emphasised 
the naivety of my original perception. Furthermore, this caused me to feel 
embarrassment as I had assumed the experiences of all types of visible 
differences would share some commonalities. Reflecting on this, I wondered if my 
struggle to understand if I was an ‘insider’ or an ‘outsider’ mirrored some of the 
experiences participants described in their difficulties to “fit in” with society and 
adhere to social norms. With this in mind, I now perceive my research position to 
be within “the space between”, acknowledging the researcher’s membership to 
the wider group whilst celebrating the differences in the group member’s 
experiences (Dwyer & Buckle, 2009, p.60).  
 
 3.6 Committed action  
The ability to be committed to our actions is an active process that allows our 
behaviour to be consistent to our values and goals, as well as providing a sense of 
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meaning (Stoddard, Nilloofar & Hayes, 2014). Before embarking on my research 
journey, I had not considered the psychological needs of people living with skin 
conditions, nor was I aware of the limited psychological services that are available 
within dermatology. Being on placement within the service that participants were 
recruited from provided me with a deeper understanding of the range of 
difficulties people living with skin conditions can encounter on a daily basis. My 
experiences have also increased my awareness of  the limited research and best 
practice guidelines that are specific to psychodermatology and the challenges this 
can cause, for both clinical work and research practices.  Whilst at times these 
challenges seemed overwhelming and complex, this area of psychology feels like 
an exciting and valuable area to complete further research within upon 
qualification. Furthermore, my research journey has affirmed to me my passion 
and motivation to work within a physical health setting, particularly towards the 
exploration of the mind-body link. I have become appreciative of what this area 
of psychology has provided me with and how it has helped marry my professional 
practice to the personal values I find meaningful. 
 
3.7 Conclusion 
Overall, my ‘dance around the hexaflex’ has allowed me to acknowledge my 
strengths and vulnerabilities, as well as the interplay between my personal and 
professional practices. I have truly valued this experience and despite the 
pressures on the NHS, I will continue to develop my reflexive skills to ensure they 
remain at the heart of my research and clinical practice. Whilst the completion of 
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my research project symbolises the end of my journey as a Trainee Clinical 
Psychologist, I believe my experiences have provided me with the necessary tools 
to ensure upon qualification I will continue to “be present, open up and do what 
matters most” (Harris, 2013, p.32). 
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         Appendix C: Quality Assessment Framework (Caldwell, Henshaw & Taylor, 2011)  
Question Yes 
(2 points) 
Partial 
(1 point) 
No 
(0 points)  
Q1. Does the title reflect the content? The title should be informative and indicate the focus of the study. It should 
allow the reader to easily interpret the context of the study. An inaccurate or misleading title can confuse the reader 
   
Q2. Are the authors Credible? Researchers should hold appropriate academic qualifications and be linked to a 
professional field relevant to the research 
   
Q3. Does the abstract summarize the key components? The abstract should provide a short summary of the study. It 
should include the aim of the study, outline of the methodology and the main findings. The purpose of the abstract is 
to allow the reader to decide if the study is of interest to them 
   
Q4. Is the rationale for undertaking the research clearly outlined? The author should present a clear rationale for the 
research, setting it in context of any current issues and knowledge of the topic to date 
   
Q5. Is the literature review comprehensive and up to date? The literature review should reflect the current state of 
knowledge relevant to the study and identify any gaps or conflicts. It should include key or classic studies on the topic 
as well as up to date literature. There should be a balance of primary and secondary sources 
   
Q6. Is the aim of the research clearly stated? The aim of the study should be clearly stated and should convey what 
the researcher is setting out to achieve  
   
Q7. Are all ethical issues identified and addressed? Ethical issues pertinent to the study should be discussed. The 
researcher should identify how the rights of informants have been protected and informed consent obtained. If the 
research is conducted within the NHS there should be an indication of local research ethics committee approval  
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Q8. Is the methodology identified and justified? The researcher should make clear what research strategy they are 
adopting, i.e. qualitative or quantitative. A clear rationale for the choice should also be provided, so that the reader 
can judge whether the chosen strategy is appropriate for the study.   
   
Q9. Quantitative Studies:  Is the study design clearly identified and a rationale provided? The design of the study e.g. 
survey, experiment should be identified and justified. As with the choice of strategy, the reader needs to determine 
whether the design is appropriate for the research undertaken  
   
Q10. Quantitative Studies:  Is there an experimental hypothesis clearly stated and are the key variable identified? In 
experimental research the researcher should provide a hypothesis. This should clearly identify the independent and 
dependent variable and state their relationship and the intent of the study. In survey research the researcher may 
choose to provide a hypothesis, but it is not essential, and alternatively a research question or aim may be provided 
   
Q11. Quantitative Studies:  Is the population identified? The population is the total number of units from which the 
researcher can gather data. It may be individuals, organisations or documentation. Whatever the unit, it must be 
clearly identified 
 
   
Q12. Quantitative Studies:  Is the sample adequately described and reflective of the population?  Both the method 
of sampling and the size of the sample should be stated so that the reader can judge whether the same is 
representative of the population and sufficiently large to eliminate bias   
   
Q13. Quantitative Studies:  Is the method of data collection valid and reliable?  The process of data collection should 
be described. The tools or instruments must be appropriate to the aims of the study and the researcher should identify 
how reliability and validity were assured  
   
Q14. Quantitative Studies:  Is the method of data analysis valid and reliable? The method of data analysis must be 
described and justified. Any statistical test used should be appropriate for the data involved.   
   
Q15. Qualitative Studies: Are the philosophical background and study design identified and the rationale for choice 
evident? The design of the study e.g. phenomenology, ethnography, should be identified and the philosophical 
background and rationale discussed. The reader needs to consider if it is appropriate to meet the aims of the study. 
   
Q16. Qualitative Studies: Are the major concepts identified? The researchers should make clear what the major 
concepts are but they might not define them. The purpose of the study is to explore the concepts from the perspective 
of the participants.  
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Q17. Qualitative Studies: Is the context of the study outlined?   The researcher should provide a description of the 
context of the study, how the study sites were determined and how the participants were selected.  
   
Q18. Qualitative Studies: Is the selection of participants described and the sampling method identified? Informants 
are selected for their relevant knowledge or experience. Representativeness is not a criteria and purpose sampling is 
often used. Sample size may be determined through saturation  
   
Q19. Qualitative Studies: Is the method of data collection auditable? Data collection methods should be described 
and be appropriate to the aims of the study. The researcher should describe how they assured that the method is 
auditable 
   
Q20. Qualitative Studies: Is the method of data analysis credible and confirmable?  The data analysis strategy should 
be identified, what processes were used to identify patterns and themes. The researcher should identify how 
credibility and confirmability have been addressed.  
   
Q21. Are the results presented in a way that is appropriate and clear? Presentation of data should be clear, easily 
interpreted and consistent  
   
Q22. Is the discussion Comprehensive?  In quantitative studies the results and discussion are presented separately. In 
qualitative studies these may be integrated. Whatever the mode of presentation the researcher should compare and 
contrast the findings with that of previous research on the topic. The discussion should be balanced and avoid 
subjectivity  
   
Q23. Quantitative Studies: Are the results generalizable?     
Q24. Qualitative Studies: Are the results transferable?     
Q25. Is the conclusion comprehensive? Conclusions must be supported by the findings. The researcher should identify 
any limitations to the study. There may also be recommendations for further research or if appropriate implications for 
practice in the relevant field.   
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Qual:1 
Quan: 1 
Qual:1 
Quan: 1 
Qual:1 
Quan: 0 
Qual:0 
Quan: 0 
Qual: 0 
0 1 Quan: 0 
Qual: 0 
1 22/50 
Scoring: 2 points= criteria fully met, 1 point = criteria partially met, 0 points= quality criteria not met  
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Appendix E: Kappa Reliability Co-efficient Data 
 
  Overall Kappa reliability co-efficient  
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora 
Approximate 
Tb 
Approximate 
Significance 
Measure of 
Agreement 
Kappa .863 .046 11.392 .000 
N of Valid Cases 90    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
 
 
Bilgic et al., (2014) Kappa reliability co-efficient  
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora 
Approximate 
Tb 
Approximate 
Significance 
Measure of 
Agreement 
Kappa .914 .037 12.052 .000 
N of Valid Cases 90    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
 
 
Liakopoulou et al., (1997) Kappa reliability co-efficient  
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora 
Approximate 
Tb 
Approximate 
Significance 
Measure of 
Agreement 
Kappa .827 .113 4.885 .000 
N of Valid Cases 18    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
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Rafique and Hunt, (2015) Kappa reliability co-efficient   
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora 
Approximate 
Tb 
Approximate 
Significance 
Measure of 
Agreement 
Kappa .852 .142 3.657 .000 
N of Valid Cases 18    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
 
 
Reeve et al., (1996) Kappa reliability co-efficient  
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora 
Approximate 
Tb 
Approximate 
Significance 
Measure of 
Agreement 
Kappa .825 .116 4.821 .000 
N of Valid Cases 18    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
 
 
Toback and Rajkumar, (1979) Kappa reliability co-efficient  
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora 
Approximate 
Tb 
Approximate 
Significance 
Measure of 
Agreement 
Kappa .793 .140 3.885 .000 
N of Valid Cases 18    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
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Appendix F: Coventry Ethical Approval for Empirical Research 
 
 
 
 
 
 
 
 
 
Certificate of Ethical Approval 
 
Applicant:  
Carly Jeffery  
 
Project Title:  
Exploring the lived experience of women with rosacea: visible difference, 
diagnosis and treatment 
 
 
This is to certify that the above named applicant has completed the Coventry University 
Ethical Approval process and their project has been confirmed and approved as High  
Risk  
 
 
 
 
 
 
 
Date of approval:  
09 March 2016  
 
 
 
Project Reference Number:  
P41490 
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Appendix G: NHS Research Ethics Committee Ethical Approval Letter  
 
 
 
 
West Midlands - Coventry & Warwickshire Research Ethics Committee  
The Old Chapel  
     Royal Standard Place  
    Nottingham  
         NG16FS  
  
  
  
 Please note:  This is the  favourable opinion of the  REC only and does not 
allow  you to start your study at NHS  sites in England until you  receive HRA 
Approval   
 
  
  
27 June 2016  
  
Miss Carly Jeffery  
Trainee Clinical Psychologist   
Coventry and Warwickshire NHS partnership trust  
Universities of Coventry and Warwick Clinical Psychology Doctorate 
Programme,   
Coventry University, James Starley Building,   
Priory Street, Coventry,   
CV1 5FB  
  
  
Dear Miss Jeffery   
  
Study title:  Exploring the lived experience of women with 
rosacea:  
visible difference, diagnosis and treatment   
REC reference:  16/WM/0218  
IRAS project ID:  198968  
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Thank you for your letter of 21 June 2016 responding to the Committee’s 
request for further information on the above research and submitting revised 
documentation.   
  
The further information has been considered on behalf of the Committee by 
the Chair.    
  
We plan to publish your research summary wording for the above study on 
the HRA website, together with your contact details. Publication will be no 
earlier than three months from the date of this opinion letter.  Should you 
wish to provide a substitute contact point, require further information, or 
wish to make a request to postpone publication, please contact the  
REC Manager, Ms Rachel Nelson,  
NRESCommittee.WestMidlands-CoventryandWarwick@nhs.net.  
Confirmation of ethical opinion  
On behalf of the Committee, I am pleased to confirm a favourable ethical 
opinion for the above research on the basis described in the application form, 
protocol and supporting documentation as revised, subject to the conditions 
specified below.  
Conditions of the favourable opinion  
The REC favourable opinion is subject to the following conditions being met 
prior to the start of the study.  
  
Management permission must be obtained from each host organisation prior to 
the start of the study at the site concerned.  
  
Management permission should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance 
arrangements. Each NHS organisation must confirm through the signing of 
agreements and/or other documents that it has given permission for the 
research to proceed (except where explicitly specified otherwise).   
Guidance on applying for NHS permission for research is available in the 
Integrated Research Application System, www.hra.nhs.uk or at 
http://www.rdforum.nhs.uk.    
  
Where a NHS organisation’s role in the study is limited to identifying and 
referring potential participants to research sites ("participant identification 
centre"), guidance should be sought from the R&D office on the information it 
requires to give permission for this activity.  
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For non-NHS sites, site management permission should be obtained in 
accordance with the procedures of the relevant host organisation.   
  
Sponsors are not required to notify the Committee of management 
permissions from host organisations  
  
 
Registration of Clinical Trials  
  
All clinical trials (defined as the first four categories on the IRAS filter page) 
must be registered on a publically accessible database within 6 weeks of 
recruitment of the first participant (for medical device studies, within the 
timeline determined by the current registration and publication trees).    
  
There is no requirement to separately notify the REC but you should do so at 
the earliest opportunity e.g. when submitting an amendment.  We will audit 
the registration details as part of the annual progress reporting process.  
  
To ensure transparency in research, we strongly recommend that all research 
is registered but for non-clinical trials this is not currently mandatory.  
  
If a sponsor wishes to contest the need for registration they should contact 
Catherine Blewett (catherineblewett@nhs.net), the HRA does not, however, 
expect exceptions to be made. Guidance on where to register is provided 
within IRAS.   
  
It is the responsibility of the sponsor to ensure that all the conditions are 
complied with before the start of the study or its initiation at a particular site (as 
applicable).  
 
Ethical review of research sites  
NHS sites  
The favourable opinion applies to all NHS sites taking part in the study, 
subject to management permission being obtained from the NHS/HSC R&D 
office prior to the start of the study (see "Conditions of the favourable 
opinion" below).  
  
Non-NHS sites  
 Approved documents  
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The final list of documents reviewed and approved by the Committee is as 
follows:  
Document    Version    Date    
Covering letter on headed paper [Covering Letter 
to Dr Brittain]   
Version 1   21 June 2016   
GP/consultant information sheets or letters [Letter 
to GP]   
Version 1   20 June 2016   
Interview schedules or topic guides for 
participants [Interview Schedule]   
Version 1   14February 
2016   
IRAS Application Form [IRAS_Form_21042016]      21 April 2016   
IRAS Application Form XML file 
[IRAS_Form_21042016]   
   21 April 2016   
IRAS Checklist XML [Checklist_21042016]      21 April 2016   
IRAS Checklist XML [Checklist_21062016]      21 June 2016   
IRAS Checklist XML [Checklist_23062016]      23 June 2016   
Letter from sponsor [Letter from Sponsor]   1   09 March 2016   
Other [Coventry University Ethical Approval 
Certificate]   
1   09 March 2016   
Other [GCP Certificate]   1   15 November 
2015  
Other [Statement of Activities]   1   18 April 2016   
Other [Schedule of events]   1   18 April 2016   
Other [Indemnity Insurance]      09 March 2016   
Other [Liability Insurance]      09 March 2016   
Other [Demographic Information Sheet]   Version 1   14 February 
2016   
Other [Participant Debrief Information Sheet]   Version 1   14 February 
2016   
Other [Consent Form- To be contacted by 
researcher]   
Version 1   14 February 
2016   
Participant consent form [Participant Consent 
Form]   
Version 2   20 June 2016   
Participant information sheet (PIS) [Participant 
Information Sheet]   
Version 3   22 June 2016   
Research protocol or project proposal [Research 
Project Proposal]   
Version 1   14 February 
2016   
Summary CV for Chief Investigator (CI) [CI CV]   1   18 April 2016   
Summary CV for supervisor (student research) 
[Carolyn Gordon]   
      
Summary CV for supervisor (student research) 
[Kate Martin]   
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Statement of compliance  
The Committee is constituted in accordance with the Governance 
Arrangements for Research Ethics Committees and complies fully with the 
Standard Operating Procedures for Research Ethics Committees in the UK.  
  
After ethical review  
Reporting requirements  
The attached document “After ethical review – guidance for researchers” 
gives detailed guidance on reporting requirements for studies with a 
favourable opinion, including:  
  
• Notifying substantial amendments  
• Adding new sites and investigators  
• Notification of serious breaches of the protocol  
• Progress and safety reports  
• Notifying the end of the study  
  
The HRA website also provides guidance on these topics, which is updated in 
the light of changes in reporting requirements or procedures.  
User Feedback  
 The Health Research Authority is continually striving to provide a high quality 
service to all applicants and sponsors. You are invited to give your view of the 
service you have received and the application procedure. If you wish to make your 
views known please use the feedback form available on the HRA website:  
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/     
  
HRA Training  
 We are pleased to welcome researchers and R&D staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/    
  
16/WM/0218                          Please quote this number on all correspondence  
  
With the Committee’s best wishes for the success of this project.  
  
Yours sincerely  
  
Dr Helen Brittain  Chair  
  
Email:NRESCommittee.WestMidlands-CoventryandWarwick@nhs.net  
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Appendix H: Health Research Authority Ethical Approval Letter  
 
 
  
  
Miss Carly Jeffery    
Trainee Clinical Psychologist                                                              Email: hra.approval@nhs.net  
Coventry and Warwickshire NHS partnership trust  
Universities of Coventry and Warwick Clinical Psychology  
Doctorate Programme,   
Coventry University, James Starley Building,   
Priory Street,  
Coventry,   
CV1 5FB  
  
30 June 2016  
  
Dear Miss Jeffery     
  
Letter of HRA Approval  
  
Study title:  Exploring the lived experience of women with rosacea:  
visible difference, diagnosis and treatment   
IRAS project 
ID:  
198968   
REC reference:  16/WM/0218    
Sponsor  Coventry and Warwick University   
  
I am pleased to confirm that HRA Approval has been given for the above referenced 
study, on the basis described in the application form, protocol, supporting documentation 
and any clarifications noted in this letter.   
  
Participation of NHS Organisations in England   
The sponsor should now provide a copy of this letter to all participating NHS organisations 
in England.   
  
Appendix B provides important information for sponsors and participating NHS 
organisations in England for arranging and confirming capacity and capability. Please 
read Appendix B carefully, in particular the following sections:  
• Participating NHS organisations in England – this clarifies the types of 
participating organisations in the study and whether or not all organisations will be 
undertaking the same activities  
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• Confirmation of capacity and capability - this confirms whether or not each type 
of participating NHS organisation in England is expected to give formal 
confirmation of capacity and capability. Where formal confirmation is not 
expected, the section also provides details on the time limit given to participating 
organisations to opt out of the study, or request additional time, before their 
participation is assumed.  
• Allocation of responsibilities and rights are agreed and documented (4.1 of 
HRA assessment criteria) - this provides detail on the form of agreement to be 
used in the study to confirm capacity and capability, where applicable.  
Further information on funding, HR processes, and compliance with HRA criteria and 
standards is also provided. It is critical that you involve both the research management 
function (e.g. R&D office) supporting each organisation and the local research team (where 
there is one) in setting up your study. Contact details and further information about 
working with the research management function for each organisation can be accessed 
from www.hra.nhs.uk/hra-approval.   
Appendices  
The HRA Approval letter contains the following appendices:  
• A – List of documents reviewed during HRA assessment  
• B – Summary of HRA assessment  
  
After HRA Approval  
The document “After Ethical Review – guidance for sponsors and investigators”, 
issued with your REC favourable opinion, gives detailed guidance on reporting expectations 
for studies, including:   
• Registration of research  
• Notifying amendments  
• Notifying the end of the study  
The HRA website also provides guidance on these topics, and is updated in the light of 
changes in reporting expectations or procedures.  
  
In addition to the guidance in the above, please note the following:  
• HRA Approval applies for the duration of your REC favourable opinion, unless 
otherwise notified in writing by the HRA.  
• Substantial amendments should be submitted directly to the Research Ethics 
Committee, as detailed in the After Ethical Review document. Non-substantial 
amendments should be submitted for review by the HRA using the form provided 
on the HRA website, and emailed to hra.amendments@nhs.net.   
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• The HRA will categorise amendments (substantial and non-substantial) and issue 
confirmation of continued HRA Approval. Further details can be found on the HRA 
website.  
  
Scope   
HRA Approval provides an approval for research involving patients or staff in NHS 
organisations in England.   
If your study involves NHS organisations in other countries in the UK, please contact the 
relevant national coordinating functions for support and advice. Further information can be 
found at http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/.  
If there are participating non-NHS organisations, local agreement should be obtained in 
accordance with the procedures of the local participating non-NHS organisation.  
  
User Feedback  
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please email the HRA 
at hra.approval@nhs.net. Additionally, one of our staff would be happy to call and discuss 
your experience of HRA Approval.   
  
HRA Training  
We are pleased to welcome researchers and research management staff at our training 
days – see details at http://www.hra.nhs.uk/hra-training/   
  
Your IRAS project ID is 198968. Please quote this on all correspondence.  
  
Yours sincerely  
  
Dr Claire Cole  
Senior Assessor   
Email: hra.approval@nhs.net   
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Appendix I: NHS Research and Development Ethical Approval Letter 
 
 
 
 
 
                                                                                                                   Tel: 0121 424 2000  
Ms Carly Jeffery                                                                                        Fax: 0121 424 2200  
Trainee Clinical Psychologist  
St Michaells Hospital  
St Michael’s Road  
Warwick  
CV34 5QW  
12  August 2016  
  
Dear Carly,  
  
Letter of access for research  
  
This letter should be presented to each participating department before 
you commence your research at this site, Heart of England NHS 
Foundation Trust  
  
In accepting this letter, each participating department confirms your right 
of access to conduct research through this organisation for the purpose 
and on the terms and conditions set out below. This right of access 
commences on 12  August 2016 and ends on 01 November 2017  unless 
terminated earlier in accordance with the clauses below.   
  
As an existing NHS employee you do not require an additional honorary 
research contract with the participating organisation. The organisation is 
satisfied that the research activities that you will undertake in the 
organisation are commensurate with the activities you undertake for your 
employer. Your employer is fully responsible for ensuring such checks as 
are necessary have been carried out.  Your employer has confirmed in 
writing to this organisation that the necessary pre-engagement checks are 
in place in accordance with the role you plan to carry out in the 
Research & Development Directorate  
MIDRU  
R&D Office: 0121 424 1633  
Fax: 0121 424 3167  
Birmingham Heartlands Hospital  
Bordesley Green East  
Birmingham B9 5SS  
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organisation.. Evidence of checks should be available on request to Heart 
of England NHS Foundation Trust..     
  
You have a right of access to conduct such research as confirmed in 
writing in the letter of permission for research from this organisation. 
Please note that you cannot start the research until the Principal 
Investigator for the research project has received a letter from us giving 
the organisation(s) permission to conduct the project.  
  
You are considered to be a legal visitor to Heart of England NHS 
Foundation Trust premises. You are not entitled to any form of payment 
or access to other benefits provided by Heart of England NHS Foundation 
Trust  to employees and this letter does not give rise to any other 
relationship between you and Heart of England NHS Foundation Trust, in 
particular that of an employee.   
  
While undertaking research through Heart of England NHS Foundation 
Trust you will remain accountable to your employer, Coventry and 
Warwickshire  Partnership NHS Trust  but you are required to follow the 
reasonable instructions of your nominated manager, Dr Kate Martin, 
Senior Clinical Pyschologist, in this organisation or those given on her 
behalf in relation to the terms of this right of access.  
  
Where any third party claim is made, whether or not legal proceedings are 
issued, arising out of or in connection with your right of access, you are 
required to cooperate fully with any investigation by West Midlands 
Ambulance Service  NHS Foundation Trust or this organisation in 
connection with any such claim and to give all such assistance as may 
reasonably be required regarding the conduct of any legal proceedings.  
  
You must act in accordance with Heart of England NHS Foundation Trust 
policies and procedures, which are available to you upon request, and the 
Research Governance Framework.   
  
You are required to co-operate with Heart of England NHS Foundation 
Trust in discharging its duties under the Health and Safety at Work etc Act 
1974 and other health and safety legislation and to take reasonable care 
for the health and safety of yourself and others while on Heart of England 
NHS Foundation Trust premises. Although you are not a contract holder, 
you must observe the same standards of care and propriety in dealing 
with patients, staff, visitors, equipment and premises as is expected of a 
contract holder and you must act appropriately, responsibly and 
professionally at all times.   
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If you have a physical or mental health condition or disability which may 
affect your research role and which might require special adjustments to 
your role, if you have not already done so, you must notify your employer 
and Heart of England NHS Foundation Trust, prior to commencing your 
research role at each site.   
  
You are required to ensure that all information regarding patients or staff 
remains secure and strictly confidential at all times. You must ensure that 
you understand and comply with the requirements of the NHS 
Confidentiality Code of Practice and the Data Protection Act 1998. 
Furthermore you should be aware that under the Act, unauthorised 
disclosure of information is an offence and such disclosures may lead to 
prosecution.   
  
The organisation will not indemnify you against any liability incurred as a 
result of any breach of confidentiality or breach of the Data Protection Act 
1998. Any breach of the Data Protection Act 1998 may result in legal 
action against you and/or your substantive employer.  
  
You should ensure that, where you are issued with an identity or security 
card, a bleep number, email or library account, keys or protective clothing, 
these are returned upon termination of this arrangement. Please also 
ensure that while on the premises you wear your ID badge at all times, or 
are able to prove your identity if challenged. Please note that the 
organisation accepts no responsibility for damage to or loss of personal 
property.  
  
This letter may be revoked  and your right to attend the organisation 
terminated at any time either by giving seven days’ written notice to you 
or immediately without any notice if you are in breach of any of the terms 
or conditions described in this letter or if you commit any act that we 
reasonably consider to amount to serious misconduct or to be disruptive 
and/or prejudicial to the interests and/or business of the organisation or if 
you are convicted of any criminal offence.  You must not undertake 
regulated activity if you are barred from such work. If you are barred from 
working with adults or children this letter of access is immediately 
terminated. Your employer will immediately withdraw you from 
undertaking this or any other regulated activity and you MUST stop 
undertaking any regulated activity immediately.  
  
Your substantive employer is responsible for your conduct during this 
research project and may in the circumstances described above instigate 
disciplinary action against you.   
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If your circumstances change in relation to your health, criminal record, 
professional registration or suitability to work with adults or children, or 
any other aspect that may impact on your suitability to conduct research, 
or your role in research changes, you must inform the organisation that 
employs you through its normal procedures. You must also inform the 
nominated manager in each participating organisation..  
  
Yours sincerely  
  
pp.   
  
  
Ms Elizabeth Adey  
Head of Research,  
Heart of England NHS Foundation Trust  
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Appendix J: Interview schedule 
 
 
 
 
 
 
Interview Structure 
 
 
 
 
Interview schedule: 
 Introduce myself to the participant and discuss the aim of the research 
 Ensure the participant has read the participant information sheet and ask if they 
have any further questions regarding the research 
 Discuss IPA research and the interview schedule  
 Allow a time for the participant to ask any questions  
 Complete the participant consent form  
 Complete the demographic information sheet 
 Ask whether they would like a summary of the project 
 Obtain permission to being audio recording of the interview 
 
Interview questions: 
 
Question One: Can you tell me a bit about yourself?  
 
Question Two: Can you tell me a bit about when you first noticed the symptoms of 
rosacea?   
Prompt: what was that like?  
 
COVENTRY AND WARWICK CLINICAL PSYCHOLOGY DOCTORATE 
Research Project Title: Exploring the lived experience of women with rosacea: 
understanding visible difference, diagnosis and treatment 
Research Project Lead: Carly Jeffery, Trainee Clinical Psychologist 
 
Version 1, Date: 14/02/2016 
Coventry University  
Priory Street, Coventry, CV1 5FB 
Telephone 0247688 8328 
Fax 024 7688 8702 
 
Programme Director 
Doctorate Course in Clinical Psychology 
Dr Eve Knight 
BSc Clin.Psy.D. CPsychol 
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Question Three: Can you tell me about being diagnosed with rosacea?  
Prompt: What was it like? Were you expecting a diagnosis? What did the diagnosis 
mean to you?  
 
Question Four: On a day to day basis, what is it like to have rosacea?  
Prompt: What does it mean to you?   
Question Five: What does a good day and a bad day with rosacea look like?  
Question Six: Tell me what it is like in social situations? 
Prompt: Has everyone reacted in this way? What have their reactions meant to 
you? How does it make you feel?  
Question Seven: What are your experiences of the management of rosacea? 
Prompts: What treatment has been offered to you? Is there anything (e.g. medical, 
emotional, social/ relationships) that helps? Why does that help?  
Question Eight:  Is there anything else you would like to share with me about your 
experience of living with Rosacea?  
Inform the participant I have finished the questions in the interview schedule and 
thank them for taking the time to participate in the project.  
 
 
 
 
 
 
General Prompts 
 Can you tell me more about that? 
 What happened? 
 How did it make you feel? 
 In what way?  
 What is that like?  
 Can you give me an example? 
Version 1, Date: 14/02/2016 Coventry University  
Priory Street, Coventry, CV1 5FB 
Telephone 0247688 8328 
Fax 024 7688 8702 
 
Programme Director 
Doctorate Course in Clinical Psychology 
Dr Eve Knight 
BSc Clin.Psy.D. CPsychol 
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Appendix K: Participant Information Sheet 
 
 
 
 
 
 
 
Participant Information Sheet 
 
 
 
 
 
 
 
Research is an important part of understanding people’s experiences so that 
professionals can provide the best care possible. I am a second year trainee clinical 
psychology doctorate student at the Universities of Coventry and Warwickshire and I 
would like to invite you to participate in the research I am currently conducting which 
focuses on the lived experience of adult women with rosacea.  
The aim of the information below is to help you decide whether or not you would like to 
take part in the research project.  
What is the aim of the research project?   
In recent years, the research that has investigated rosacea has started to shape the 
psychological understanding of the condition. However, the lived experiences of people 
diagnosed with this condition remains a neglected area within the literature. The aim of 
this project is to explore women’s experiences of having rosacea. It is hoped the 
information that is collected will provide a greater understanding of: 
 What it is like to have rosacea 
 The experience of being diagnosed with the condition  
 The experience of social situations for women with rosacea 
 What it is like to try and manage the condition 
 
 
 
 
 
COVENTRY AND WARWICK CLINICAL PSYCHOLOGY DOCTORATE 
Research Project Title: Exploring the lived experience of women with rosacea: 
understanding visible difference, diagnosis and treatment 
Research Project Lead: Carly Jeffery, Trainee Clinical Psychologist 
Email: jefferyc@uni.coventry.ac.uk 
General Office Telephone Number: 02476 888328 
Address: Clinical Psychology Doctorate Programme, Coventry University, Faculty of 
Health and Life Sciences, James Starley Building, Priory Street, Coventry, CV1 5FB.  
  
 IRAS ID: 198968, Version 4.1, Date: 29/06/2016 
Coventry University  
Priory Street, Coventry, CV1 5FB 
Telephone 0247688 8328 
Fax 024 7688 8702 
 
Programme Director 
Doctorate Course in Clinical Psychology 
Dr Eve Knight 
BSc Clin.Psy.D. CPsychol 
 
 
Dean of Faculty of Health and Life Sciences  
Professor Guy Daly Coventry University Priory Street Coventry CV1 5FB Tel 024 7679 5805  
 
Head of Department of Psychology 
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Who will be asked to take part?  
Up to eight females aged 20 and above who have had a clinical diagnosis of rosacea for 
over 6 months will be invited to take part in the research project. Participants need to 
have previously been or are currently being supported by the Dermatology Services 
within the Heart of England NHS Foundation Trust.  
 
Who will decide if I should participate in the research?   
It is your decision whether you participate in the research project or not. Any decision 
you make will not affect the medical treatment you receive now or in the future. Your 
information will only be used in the project if you consent to its use.  
 
If I agree to take part, what is involved in the research project?  
If you wish to participate in the research project, you will be invited to take part in an 
interview with the project lead. Prior to the interview, you will be asked to complete a 
consent form and a demographic information sheet which asks you to provide 
information about your age, ethnicity, date you were diagnosed with rosacea and 
condition subtype (if known).  
The interview   
The interview will last approximately 60 minutes and will involve an informal discussion 
where the researcher hopes to find out about your experiences of living with rosacea. 
The project lead will ask a range of questions which will cover areas related to this topic. 
You do not have to answer any questions if you do not wish to and can stop the interview 
at any time.  
 
If, in the interview you disclose information that is a cause of concern for either your 
safety or the safety of other people, the project lead will liaise with the appropriate 
service to provide support. Should this issue arise, it will be discussed with you in more 
detail.  
The interviews will be audio recorded for the purpose of transcription. Once the research 
project has been marked and approved by Coventry and Warwick Universities, the audio 
tapes and any confidential information obtained for the purpose of the project will be 
destroyed.   
 
 
 
 
 
IRAS ID: 198968, Version 4.1, Date: 29/06/2016 
Coventry University  
Priory Street, Coventry, CV1 5FB 
Telephone 0247688 8328 
Fax 024 7688 8702 
 
Programme Director 
Doctorate Course in Clinical Psychology 
Dr Eve Knight 
BSc Clin.Psy.D. CPsychol 
 
 
Dean of Faculty of Health and Life Sciences  
Professor Guy Daly Coventry University Priory Street Coventry CV1 5FB Tel 024 7679 5805  
 
Head of Department of Psychology 
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Will other people be able to identify me in the research?  
All personal information such as name, date of birth, names of friends and family, where 
you live etc. will not be included in the findings of the research project. Only the project 
lead will have access to this information and this will be kept separately from the 
transcripts. Any information that could identify you will be anonymised. You will not be 
able to be identified in the research project.  
 
The project will use extracts of the transcripts to highlight themes that arise from 
participant’s experiences. A pseudonym will be used, which means the reader would not 
be able to identify you.  Any personal information that could identify you will be kept 
confidential and will not be included in the findings of the project.  
Anonymised transcripts may be shared with the research supervisory team to aid the 
process of identifying themes that emerge from the information that is provided by 
participants. 
 
What are the possible advantages and disadvantages of taking part? 
Advantages: An opportunity to ‘give voice’ to your experiences of rosacea. It is hoped the 
information that is provided will add to our understanding of rosacea and inform future 
practices.  
 
Disadvantages: It is not anticipated you will experience any disadvantages by taking part 
in this research project. Before you decide whether to take part or not it is important to 
think about how it may feel to discuss your experience of having rosacea and whether 
this is likely to be a particularly challenging or difficult experience for you.  
 
Do I have the right to withdraw my consent?  
If you have previously consented to your information being used in the research project 
and decide you wish to withdraw your consent, you can do so up to one month after your 
interview took place. After this time, the data will be analysed in preparation for writing 
the research project. You can withdraw from the research by contacting the project lead 
on the contact details listed above.  
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What if something goes wrong? 
If you experience any psychological distress during the interview, you will be asked if you 
would like to have a break or continue with the interview. You will also be reminded of 
your right to withdraw from the interview at any time.  
 
If you find discussing your experiences of living with rosacea particularly distressing, the 
project lead will discuss the possible options of support that are available to you. This 
may include encouraging you to contact your GP to discuss how you are feeling. The 
project lead may also make a referral with your consent, to an appropriate service for 
support. After the interview, you will also be provided with a Debrief Information Sheet 
which will contain information about the available services you can access for advice and 
support.  
 
What are the contact details for the Patient Advice and Liaison Service?  
The Patient Advice and Liaison Service (PALS) for the Heart of England NHS Foundation 
Trust has changed its name to the Patient Services Department. This service provides 
support to service users, relatives and carers who have concerns, complaints or queries 
about the service that has been provided to them by the NHS. You can contact the 
Patient Services Department either via telephone on: 0121 424 0808 or their email 
address: bhs-tr.Complaints-ConcernsandCompliments@nhs.net 
 
Will any healthcare professionals involved in my care be made aware of my 
participation in the research project?  
If you decide to participate in the research project, you will be asked if you would like 
your General Practitioner (GP) to be informed of your participation in the research 
project. If you provide your consent, the chief investigator will write to your GP to let 
them know you are taking part.  
 
What will happen to the results of this research project? 
It is anticipated the research project will be submitted to a journal article for publication, 
as well as being presented to staff and colleagues affiliated with the Coventry and 
Warwick Clinical Psychology doctorate programme and at other appropriate conferences.  
Feedback on the overall research findings will also be made available to staff within the 
dermatology department at the Heart of England NHS Foundation Trust.  
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If I consent, can I have a copy of the results? 
If you consent to participating in the project, before your interview you will be asked 
whether you would like to have a summary of the overall findings and conclusion of the 
research project. If you inform the project lead you would like a copy of this summary it 
will be available once the project has been submitted and approved by the Coventry and 
Warwick doctorate programme in the summer of 2017.  
 
Who has approved the research project? 
 
The research project is sponsored by Coventry University. It has been reviewed and 
approved by Coventry University ethics committee, NHS research ethics committee and 
the research and development department for the Heart of England NHS Foundation 
Trust.  
 
I am interested in taking part, what happens next?           
If you are interested in taking part in the project, you will be provided with a consent 
form. This form asks for your consent for me to contact you about the project and what 
your preferred contact details are. You can either post your completed consent forms to 
me at the address listed above, or, you can contact me directly via email on: 
jefferyc@uni.coventry.ac.uk  
 
If there is anything that you don’t understand about the aims and purpose of the study or 
you would like more information, please do not hesitate to contact me on the contact 
details listed above and I would be happy to answer any questions you may have. If you 
contact me for further information this does not mean that you are obliged to take part 
in the project. 
 
Thank you for taking the time to read this information and in your consideration of 
whether you wish to participate in this project.  
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Appendix L: Consent form 1 (Consent to be contacted by the researcher) 
 
 
 
 
 
 
 
 
Participant Consent Form- Consent to be contacted by the project lead 
 
 
 
 
 
 
 
 
Please read the statements below and if you agree, please initial each box:  
 
I confirm I have read and understood the participant information sheet for the  
above project and I am interested in taking part 
 
 
I am aware by signing below, I am providing my consent for the project lead to 
 contact me to provide more information about the research project and answer  
any questions or queries I may have about the project 
 
 
I understand the medical treatment I receive now or in the future will not be  
affected by my decision to participate/not participate in this research project 
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Participant Information:         
 
Name (Please print):………………………………………………………… 
  
My preferred contact details are: …………………………………… 
 
Signature: …………………………………………................................  
 
Date: …………………………………………………………………………….. 
 
 
Thank you for registering your interest in the research project, please can you send your 
completed consent forms to Carly Jeffery (Trainee Clinical Psychologist) at the address 
listed above. You can also contact me directly via my email address listed above.  
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Appendix M: Consent form 2 
 
 
 
 
 
 
 
Participant Consent Form 
 
 
 
 
 
 
Please read the statements below and if you agree, please initial each box: 
 
I confirm I have read and understood the participant information sheet 
for the above project and by signing below I consent to participate  
in this project 
  
 
I am aware of what will be involved in the research project and that 
 the interview will be audio recorded and transcribed  
 
 
I am aware I will be asked to provide demographic information about  
myself such as my age, ethnicity, date of diagnosis of rosacea  
and condition subtype (if known) 
 
 
Any questions I have had about the project have been answered and 
 I am aware who I can contact about the research project if I need to  
do so 
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I have been informed participation is the research project is entirely 
 voluntary and I can withdraw the information I provide up to one  
month after my interview 
 
 
I understand a pseudonym will be used in the research project and 
 I consent to extracts of my interview being used in the report and 
 in publication 
 
 
I understand the academic and clinical supervisors of this research  
may look at the transcripts of the interviews which have been  
anonymised 
 
 
I am aware how my data will be treated in the project and I 
understand my personal information will not be included in the 
project 
 
 
I provide my consent for my General Practitioner (GP) to be  
informed of my participation in the research project 
 
 
I agree to take part in the research project 
 
 
Participant:      Research Project Lead:  
Name:       Name:   
 
Signature:       Signature: 
 
Date:       Date:  
 
  
 
1 copy to participant, 1 copy for researcher site file 
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Appendix N: Participant Demographic Information Sheet 
 
 
 
 
 
 
 
Participant Demographic Information Sheet 
 
 
 
 
 
 
 
Name:  
Age:  
Ethnicity:  
Rosacea Subtype (if known): 
Date received diagnosis of rosacea:  
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Appendix O: Participant Debrief Information Sheet 
 
 
 
 
 
Participant Debrief Information Sheet 
 
 
 
 
 
 
Thank you for taking part in my research project. Within the interview, I asked you a 
number of questions about your experience of having Rosacea, particularly your thoughts 
and feelings towards visible difference, diagnosis and management of the condition.   
What happens to the information you have provided 
The information provided in the interviews will now be transcribed. All personal 
information that could identify you will be anonymised and will not be used in the 
research report. Only extracts of participants transcripts will be incorporated into the 
report and a pseudonym will be used. This means the reader will not be able to identify 
you.  
 
In the transcripts, I will look for the main themes that have emerged from the interviews 
to encapsulate the lived experience of rosacea.  The transcripts and audio recording will 
be destroyed once the research project has been submitted for marking and approved by 
the Coventry and Warwick Clinical Psychology Doctorate programme.  
 
How to withdraw your information from the project 
If you wish to withdraw the information you have provided in the interview, please 
contact me using the details listed above. You can withdraw your consent up to one 
month after your interview took place.  
 
 
 
 
Coventry University  
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Findings of the research project 
If you have confirmed you would like to know the overall conclusion and findings of the 
research project, you will be sent a copy once the project has been marked and approved 
by the Coventry and Warwick  
University Doctorate Programme. The research project will be submitted for marking in the 
summer of 2017.  
 
Support Services:  
Whilst it is not the intension of the research project to cause any distress, if you found 
discussing your experience of rosacea particularly challenging and/or upsetting, you may 
wish to discuss how you are feeling with someone. You can contact your GP, or 
alternatively there are a number of services available which you can access for support. I 
have included the contact details of these services below.  
 
Changing Faces – UK based charity which offers practical and emotional support as well as 
information aimed at supporting individuals and families living with visible difference  
Telephone number: 0300 0120 2759 (Weekdays 9am-5pm) 
Website: www.changingfaces.org.uk 
Mind- offers a range of practical advice, information and support for people experiencing 
mental health difficulties.  
Telephone number: 0300 123 3393 (Weekdays 9am - 6pm) 
Website: www.mind.org.uk 
Samaritans- offers a range of services including emotional support, advice and information  
Telephone Number: 08457 90 90 90 (available 24 hours) 
Website: http://www.samaritans.org 
 
 
Thank you again for taking the time to share your experiences 
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Appendix P: GP Letter 
 
 
 
 
 
 
 
 
Date 
Dear Dr ,  
 
Re: Name of Participant, DOB:  
 
I am writing to you to inform you (name of participant) has provided their 
consent to participate in a qualitative research project exploring the lived 
experience of women with rosacea. Within the project, participants will be 
asked to complete a 60-80 minute semi-structured interview which aims to 
explore: 1) what it is like to have rosacea, 2) the experience of being diagnosed 
with the condition, 3) the experience of social situations for women with 
rosacea, 4) what it is like to try and manage the condition.  
 
The research is being completed as part of the Coventry and Warwick Clinical 
Psychology Doctorate Course and has been approved by Coventry University 
ethics committee, NHS research ethics committee and the research and 
development department for the Heart of England Foundation Trust. (Name of 
participant) has provided their consent for you to be informed of their 
participation in the project.  
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A copy of the participant information sheet has been enclosed with this letter 
to provide additional information about the research project. This includes 
information on the aim of the study, method of data collection, inclusion 
criteria and ethical considerations. If you require any further information 
regarding the research project, please do not hesitate to contact me using my 
contact details listed below.  
Kind regards, 
 
Carly Jeffery 
Trainee Clinical Psychologist 
Universities of Coventry and Warwick 
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Appendix Q: IPA Guidelines (Smith, Flowers & Larkin, 2009) 
 
Step Description 
1: Reading and 
re-reading 
Reading and re-reading a participant’s transcript enabled the 
researcher to become immersed in the data. This included 
listening to the audio-recording of the interview while reading 
the transcript. 
2: Initial Coding A detailed line by line analysis of the transcript was completed to 
draw out the meaning held within participant’s dialogue. This 
included noting important descriptive, linguistic and conceptual 
information.  
3 Developing 
emergent 
themes 
This step involved identifying and developing the themes that 
emerged from the initial coding process of a participant’s 
transcript.  
4 Searching for 
connections 
across emergent 
themes 
The connections between emergent themes were analysed to 
develop a structure that reflected the researcher’s interpretation 
of meaningful and important aspects of participant’s 
experiences.  
5 Moving to the 
next case 
Following the analysis of a participant’s transcript the identified 
themes were bracketed to prevent the researcher’s fore-
structure restricting the themes that emerged within other 
participant’s dialogue. Steps 1-5 were repeated for each 
transcript.  
6 Looking for 
patterns across 
cases  
The themes from participant transcripts were organised into 
subordinate and super-ordinate themes. Convergence and 
divergence across participant’s subthemes was also considered 
during this process.   
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Appendix R: Extract of Participant’s Transcript Analysis  
Participant 3 
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Participant 4:  
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Appendix S: Photo of data analysis 
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